@NP	Animals	758
@NP	a photochemical injury of 2.5 min irradiation at the T8 spinal cord segment	784
@NP	a photochemical injury	784
@NP	2.5 min irradiation at the T8 spinal cord segment	810
@NP	2.5 min irradiation	810
@NP	the T8 spinal cord segment	833
@NP	lesion	867
@NP	a suspension containing 180,000 OECs or SCs	875
@NP	a suspension	875
@NP	180,000 OECs or SCs	899
@NP	A control group -LRB- group DM -RRB-	933
@NP	A control group	933
@NP	group DM	950
@NP	the vehicle	969
@NP	3 months	995
@NP	behavioral skills	1017
@NP	open field-BBB scale , inclined plane , and thermal algesimetry tests	1054
@NP	open field-BBB scale	1054
@NP	inclined plane	1076
@NP	thermal algesimetry tests	1096
@NP	Motor -LRB- MEPs -RRB- and somatosensory	1123
@NP	Motor -LRB- MEPs -RRB-	1123
@NP	Motor	1123
@NP	MEPs	1130
@NP	somatosensory	1140
@NP	potentials -LRB- SSEPs -RRB-	1161
@NP	potentials	1161
@NP	SSEPs	1173
@NP	the integrity of spinal cord pathways	1207
@NP	the integrity	1207
@NP	spinal cord pathways	1224
@NP	lumbar spinal reflexes	1254
@NP	the H reflex responses	1295
@NP	Glial fibrillary acidic protein and proteoglycan expressions	1319
@NP	Glial fibrillary acidic protein	1319
@NP	proteoglycan expressions	1355
@NP	the injured spinal segments	1421
@NP	the preservation of corticospinal and raphespinal tracts	1454
@NP	the preservation	1454
@NP	corticospinal and raphespinal tracts	1474
@NP	the lesion was evaluated	1521
@NP	the lesion	1521
@NP	Both OEC - and SC-transplanted groups	1547
@NP	Both OEC	1547
@NP	SC-transplanted groups	1561
@NP	significantly better results	1591
@NP	all the behavioral tests than the DM group	1623
@NP	all the behavioral tests	1623
@NP	the DM group	1653
@NP	the OEC group	1680
@NP	higher MEP amplitudes and lower H responses	1698
@NP	higher MEP amplitudes	1698
@NP	lower H responses	1724
@NP	the other two groups	1747
@NP	the injury site	1772
@NP	the area of spared parenchyma	1789
@NP	the area	1789
@NP	spared parenchyma	1801
@NP	transplanted than in control injured rats	1834
@NP	control	1855
@NP	OEC-transplanted animals	1877
@NP	astrocytic reactivity and proteoglycan expression in comparison	1914
@NP	astrocytic reactivity and proteoglycan expression	1914
@NP	comparison	1967
@NP	SC-transplanted and DM rats	1983
@NP	these results	2028
@NP	transplantation of both OEC and SC	2056
@NP	transplantation	2056
@NP	both OEC and SC	2075
@NP	OEC	2080
@NP	SC	2088
@NP	potential for restoration of injured spinal cords	2095
@NP	potential	2095
@NP	restoration of injured spinal cords	2109
@NP	restoration	2109
@NP	injured spinal cords	2124
@NP	OEC grafts	2146
@NP	superior ability	2164
@NP	glial reactivity	2191
@NP	functional recovery	2223
@NP	The failure	2245
@NP	the mammalian central nervous system -LRB- CNS -RRB- axons	2260
@NP	CNS	2298
@NP	an injury and the chronic functional deficits caused in patients	2329
@NP	an injury	2329
@NP	the chronic functional deficits caused in patients	2343
@NP	the chronic functional deficits	2343
@NP	patients	2385
@NP	many groups	2410
@NP	possible therapies	2437
@NP	CNS repair	2467
@NP	Traumatic spinal cord injuries	2479
@NP	the death of gray matter neurons	2525
@NP	the death	2525
@NP	gray matter neurons	2538
@NP	the disruption	2565
@NP	white matter tracts	2608
@NP	the site of the injury	2631
@NP	the site	2631
@NP	the injury	2643
@NP	the loss of motor , sensory , and autonomic control	2666
@NP	the loss	2666
@NP	motor , sensory , and autonomic control	2678
@NP	motor	2678
@NP	sensory	2685
@NP	autonomic control	2698
@NP	the site of injury	2722
@NP	the site	2722
@NP	injury	2734
@NP	the different therapies	2753
@NP	Olson , 1997 ; Horner and Gage , 2000	2786
@NP	Olson	2786
@NP	1997 ; Horner and Gage	2793
@NP	1997	2793
@NP	Horner and Gage	2799
@NP	2000	2816
@NP	cell grafting	2823
@NP	a powerful and promising tool for enhancing restitution of the lost functions	2852
@NP	a powerful and promising tool	2852
@NP	restitution of the lost functions	2896
@NP	restitution	2896
@NP	the lost functions	2911
@NP	SCs and OECs	3541
@NP	special attention	3568
@NP	the gap	3599
@NP	spinal cord injuries	3613
@NP	Several experiments	3635
@NP	regeneration of central axons	3668
@NP	regeneration	3668
@NP	central axons	3684
@NP	peripheral nerve or SC grafts	3703
@NP	Richardson	3734
@NP	et al. , 1980 ; Paino and Bunge , 1991 ; Xu et al. , 1995 ; Guest et al. , 1997	3745
@NP	et al. , 1980	3745
@NP	et al.	3745
@NP	1980	3753
@NP	Paino and Bunge , 1991	3759
@NP	Paino and Bunge	3759
@NP	1991	3776
@NP	Xu et al. , 1995	3782
@NP	Xu	3782
@NP	et al. , 1995	3785
@NP	et al.	3785
@NP	1995	3793
@NP	Guest et al. , 1997	3799
@NP	Guest	3799
@NP	et al. , 1997	3805
@NP	et al.	3805
@NP	1997	3813
@NP	the rich trophic environment produced by the SCs	3836
@NP	the rich trophic environment	3836
@NP	the SCs	3877
@NP	the elongation of propiospinal and supraspinal axons within the graft	3894
@NP	the elongation of propiospinal	3894
@NP	the elongation	3894
@NP	propiospinal	3912
@NP	supraspinal axons within the graft	3929
@NP	supraspinal axons	3929
@NP	the graft	3954
@NP	it	3974
@NP	central axons	4000
@NP	the host cord	4035
@NP	the distal interface	4054
@NP	the graft -LRB- Xu et al. , 1997 ; Plant et al. , 2001 -RRB-	4078
@NP	the graft	4078
@NP	Xu	4089
@NP	et al. , 1997 ; Plant et al. , 2001	4092
@NP	et al.	4092
@NP	1997 ; Plant et al.	4100
@NP	1997	4100
@NP	Plant et al.	4106
@NP	Plant	4106
@NP	et al.	4112
@NP	2001	4120
@NP	the other hand	4130
@NP	the particular regenerative properties	4146
@NP	the adult mammalian olfactory system	4188
@NP	continuous regeneration of peripheral olfactory neurons	4238
@NP	continuous regeneration	4238
@NP	peripheral olfactory neurons	4265
@NP	the life of the animal	4305
@NP	the life	4305
@NP	the animal	4317
@NP	the OECs -LRB- Doucette , 1984 -RRB-	4361
@NP	the OECs	4361
@NP	Doucette	4371
@NP	1984	4381
@NP	Grafts of OECs into complete or partial spinal cord lesions	4388
@NP	Grafts	4388
@NP	OECs into complete or partial spinal cord lesions	4398
@NP	OECs	4398
@NP	complete or partial spinal cord lesions	4408
@NP	axonal regeneration	4456
@NP	Li	4477
@NP	et al. , 1997 ; Ramo ' n - Cueto et al. , 2000 ; Lu et al. , 2002	4480
@NP	et al.	4480
@NP	1997 ; Ramo ' n - Cueto et al. , 2000 ; Lu et al.	4488
@NP	1997 ; Ramo ' n	4488
@NP	1997	4488
@NP	Ramo ' n	4494
@NP	Ramo '	4494
@NP	Cueto et al. , 2000	4502
@NP	Cueto	4502
@NP	et al. , 2000	4508
@NP	et al.	4508
@NP	2000	4516
@NP	Lu et al.	4522
@NP	Lu	4522
@NP	et al.	4525
@NP	2002	4533
@NP	functional recovery	4543
@NP	Ramo ' n-Cueto et al. , 2000 ; Lu et al. , 2002 ; Verdu ' et al. , 2003b	4564
@NP	Ramo ' n-Cueto et al.	4564
@NP	Ramo ' n-Cueto	4564
@NP	Ramo '	4564
@NP	et al.	4577
@NP	2000 ; Lu et al.	4585
@NP	2000	4585
@NP	Lu et al.	4591
@NP	Lu	4591
@NP	et al.	4594
@NP	2002 ; Verdu ' et al. , 2003b	4602
@NP	2002	4602
@NP	Verdu ' et al. , 2003b	4608
@NP	Verdu '	4608
@NP	et al. , 2003b	4615
@NP	et al.	4615
@NP	2003b	4623
@NP	future therapeutic strategies	4644
@NP	spinal cord injury	4678
@NP	the important question	4698
@NP	OECs and SCs	4739
@NP	comparable cell types	4756
@NP	they	4789
@NP	fact	4798
@NP	specific effects	4812
@NP	one of them most suitable	4837
@NP	one	4837
@NP	them	4844
@NP	special applications -LRB- Wewetzer et al. , 2002 -RRB-	4867
@NP	special applications	4867
@NP	Wewetzer	4889
@NP	et al. , 2002	4898
@NP	et al.	4898
@NP	2002	4906
@NP	Only a few studies in the literature	4913
@NP	Only a few studies	4913
@NP	the literature	4935
@NP	the effects of SC and OEC transplants	4964
@NP	the effects	4964
@NP	SC and OEC transplants	4979
@NP	injured spinal cords	5005
@NP	spinal cord focal demyelination	5033
@NP	Akiyama et al. -LRB- 2002 -RRB-	5066
@NP	Akiyama et al.	5066
@NP	Akiyama	5066
@NP	et al.	5074
@NP	2002	5082
@NP	following intravenous injection	5103
@NP	bone marrow cells , SCs , or OECs , only the former	5138
@NP	bone marrow cells	5138
@NP	SCs	5157
@NP	OECs , only the former	5165
@NP	OECs	5165
@NP	only the former	5171
@NP	the injured spinal cords	5212
@NP	Imaizumi et al. -LRB- 2000 -RRB-	5238
@NP	Imaizumi et al.	5238
@NP	Imaizumi	5238
@NP	et al.	5247
@NP	2000	5255
@NP	a dorsal hemisection model of the spinal cord	5271
@NP	a dorsal hemisection model	5271
@NP	the spinal cord	5301
@NP	both SC and OEC transplants	5322
@NP	SC	5327
@NP	OEC transplants	5334
@NP	spinal cord conduction	5358
@NP	axonal regeneration	5393
@NP	the transection site	5420
@NP	Another recent study	5442
@NP	delayed transplantation of SCs but not of OECs	5475
@NP	delayed transplantation	5475
@NP	SCs but not of OECs	5502
@NP	SCs	5502
@NP	OECs	5517
@NP	locomotor recovery	5531
@NP	a moderate contusion to the spinal cord -LRB- Takami et al. , 2002 -RRB-	5556
@NP	a moderate contusion	5556
@NP	the spinal cord -LRB- Takami et al. , 2002 -RRB-	5580
@NP	the spinal cord	5580
@NP	Takami	5597
@NP	et al. , 2002	5604
@NP	et al.	5604
@NP	2002	5612
@NP	The aim of the present work	5619
@NP	The aim	5619
@NP	the present work	5630
@NP	the functional outcome of animals with OEC or SC	5662
@NP	the functional outcome	5662
@NP	animals with OEC or SC	5688
@NP	animals	5688
@NP	OEC or SC	5701
@NP	a photochemical injury to the spinal cord	5745
@NP	a photochemical injury	5745
@NP	the spinal cord	5771
@NP	the neuroprotection properties of these grafts	5803
@NP	the neuroprotection properties	5803
@NP	these grafts	5837
@NP	glial reactivity and spinal cord connectivity	5862
@NP	glial reactivity	5862
@NP	spinal cord connectivity	5883
@NP	MATERIALS AND METHODS	5910
@NP	SC and OEC Culture Primary cultures of SCs and OECs from adult Sprague	5932
@NP	SC and OEC Culture Primary cultures	5932
@NP	SC and OEC Culture	5932
@NP	Primary cultures	5951
@NP	SCs and OECs from adult Sprague	5971
@NP	SCs and OECs	5971
@NP	adult Sprague	5989
@NP	Dawley rats	6004
@NP	detail elsewhere -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	6081
@NP	detail elsewhere -LRB- Verdu ' et al.	6081
@NP	detail elsewhere	6081
@NP	Verdu ' et al.	6099
@NP	Verdu '	6099
@NP	et al.	6106
@NP	2001	6114
@NP	2003b	6120
@NP	transplantation	6132
@NP	frozen cell vials	6149
@NP	37 Â°C	6182
@NP	centrifugation -LRB- 900 rpm , 7 min -RRB-	6207
@NP	centrifugation	6207
@NP	900 rpm , 7 min	6223
@NP	900 rpm	6223
@NP	7 min	6232
@NP	Dulbecco 's	6242
@NP	Eagle 's medium nutrient	6262
@NP	Eagle 's	6262
@NP	mixture F-12 Ham -LRB- DMEM ; D8900 ; Sigma , St.	6286
@NP	mixture F-12 Ham -LRB- DMEM ; D8900	6286
@NP	mixture F-12 Ham	6286
@NP	DMEM ; D8900	6304
@NP	DMEM	6304
@NP	D8900	6310
@NP	Sigma , St.	6317
@NP	Louis , MO -RRB- , and the pellet was resuspended in the same medium .	6328
@NP	Louis , MO -RRB- , and the pellet	6328
@NP	Louis , MO -RRB-	6328
@NP	Louis	6328
@NP	the pellet	6344
@NP	the same medium	6374
@NP	The cells	6391
@NP	2 hr of thawing	6426
@NP	2 hr	6426
@NP	thawing	6434
@NP	our conditions , most	6449
@NP	our conditions	6449
@NP	most	6465
@NP	transplanted OECs	6470
@NP	spindle-shaped , p75-positive cells , described as having an SClike phenotype	6492
@NP	spindle-shaped , p75-positive cells	6492
@NP	an SClike phenotype	6548
@NP	Franceschini and Barnett	6569
@NP	1996 ; GudinËo - Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al.	6595
@NP	1996 ; GudinËo	6595
@NP	1996	6595
@NP	GudinËo	6601
@NP	Cabrera and Nieto-Sampedro , 2000	6610
@NP	Cabrera and Nieto-Sampedro	6610
@NP	2000	6638
@NP	Wewetzer et al.	6644
@NP	Wewetzer	6644
@NP	et al.	6653
@NP	2002	6661
@NP	The purity of transplanted SCs	6668
@NP	The purity	6668
@NP	transplanted SCs	6682
@NP	80 %	6709
@NP	Spinal Cord	6714
@NP	Injury and Cell Transplants	6726
@NP	Twenty-four adult female Sprague-Dawley rats	6754
@NP	200 -- 250 g	6800
@NP	200	6800
@NP	250 g	6805
@NP	sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	6835
@NP	sodium pentobarbital	6835
@NP	50 mg/kg , i.p.	6857
@NP	50 mg/kg	6857
@NP	a heating pad	6893
@NP	the body temperature constant	6915
@NP	The thoracic back area	6946
@NP	povidone iodine	7001
@NP	a longitudinal incision	7022
@NP	the skin and muscles extending from middle to low thoracic vertebrae	7049
@NP	the skin and muscles	7049
@NP	middle to low thoracic vertebrae	7085
@NP	The spinal cord	7128
@NP	a dorsal laminectomy	7159
@NP	the T8 vertebra	7183
@NP	Rose Bengal -LRB- RB ; 1.5 % in saline solution ; Sigma -RRB-	7200
@NP	Rose Bengal	7200
@NP	RB ; 1.5 % in saline solution ; Sigma	7213
@NP	RB	7213
@NP	1.5 % in saline solution ; Sigma	7217
@NP	1.5 % in saline solution	7217
@NP	1.5 %	7217
@NP	saline solution	7225
@NP	Sigma	7242
@NP	the spinal cord dorsal surface for 10 min and the excess	7276
@NP	the spinal cord dorsal surface	7276
@NP	10 min and the excess	7311
@NP	10 min	7311
@NP	the excess	7322
@NP	saline solution rinses	7350
@NP	saline solution	7350
@NP	the spinal cord	7380
@NP	an optic fiber	7417
@NP	10 mm above the spinal cord	7444
@NP	10 mm	7444
@NP	the spinal cord	7456
@NP	a cold light source equipped with a halogen bulb	7486
@NP	a cold light source	7486
@NP	a halogen bulb	7520
@NP	All the spinal cords	7536
@NP	an intensity of 80 kLux for 2.5 min	7579
@NP	an intensity	7579
@NP	80 kLux for 2.5 min	7595
@NP	80 kLux	7595
@NP	2.5 min	7607
@NP	damage caused by the calorific source of the lamp	7627
@NP	damage	7627
@NP	the calorific source of the lamp	7644
@NP	the calorific source	7644
@NP	the lamp	7668
@NP	the spinal cord	7678
@NP	saline solution	7710
@NP	the illumination time -LRB- Verdu ' et al. , 2003a , b -RRB-	7733
@NP	the illumination time	7733
@NP	Verdu ' et al. , 2003a , b	7756
@NP	Verdu ' et al. , 2003a	7756
@NP	Verdu '	7756
@NP	et al. , 2003a	7763
@NP	et al.	7763
@NP	2003a	7771
@NP	Thirty minutes	7781
@NP	injury	7802
@NP	the animals	7810
@NP	four injections	7831
@NP	a suspension of OECs -LRB- 45,000 in 3 Âµl DMEM each ; group OEC , n = 8 -RRB-	7850
@NP	a suspension	7850
@NP	OECs -LRB- 45,000 in 3 Âµl DMEM each ; group OEC , n = 8 -RRB-	7866
@NP	OECs	7866
@NP	45,000 in 3 Âµl DMEM each ; group OEC , n = 8	7872
@NP	45,000	7872
@NP	3 Âµl DMEM each ; group OEC , n	7882
@NP	3 Âµl DMEM each	7882
@NP	3 Âµl DMEM	7882
@NP	each	7892
@NP	group OEC , n	7898
@NP	group OEC	7898
@NP	n	7909
@NP	8	7913
@NP	a suspension of SCs -LRB- 45,000 in 3 Âµl DMEM each ; group SC , n = 8 -RRB-	7919
@NP	a suspension	7919
@NP	SCs -LRB- 45,000 in 3 Âµl DMEM each ; group SC , n = 8 -RRB-	7935
@NP	SCs	7935
@NP	45,000 in 3 Âµl DMEM each ; group SC , n = 8	7940
@NP	45,000	7940
@NP	3 Âµl DMEM each ; group SC , n	7950
@NP	3 Âµl DMEM each	7950
@NP	3 Âµl DMEM	7950
@NP	each	7960
@NP	group SC , n	7966
@NP	group SC	7966
@NP	n	7976
@NP	8	7980
@NP	the exposed spinal cord	7988
@NP	Each animal	8013
@NP	a total of 180,000 OECs or SCs	8034
@NP	a total	8034
@NP	180,000 OECs or SCs	8045
@NP	180,000 OECs	8045
@NP	SCs	8061
@NP	The control group	8066
@NP	animals	8097
@NP	four injections of an equal volume of DMEM	8119
@NP	four injections	8119
@NP	an equal volume of DMEM	8138
@NP	an equal volume	8138
@NP	DMEM	8157
@NP	group DM , n = 8	8169
@NP	group DM	8169
@NP	n = 8	8179
@NP	n	8179
@NP	8	8183
@NP	The injections	8187
@NP	the rostral and caudal edges	8215
@NP	the rostral	8215
@NP	caudal edges	8231
@NP	laterally to the midplane of the exposed spinal cord segment	8248
@NP	the midplane of the exposed spinal cord	8261
@NP	the midplane	8261
@NP	the exposed spinal cord	8277
@NP	The suspensions	8310
@NP	a glass micropipette -LRB- 80 Âµm i.d. -RRB-	8347
@NP	a glass micropipette	8347
@NP	80 Âµm i.d.	8369
@NP	means of repeated pulses of 20 msec duration and 10 psi	8384
@NP	means	8384
@NP	repeated pulses of 20 msec duration and 10 psi	8393
@NP	repeated pulses	8393
@NP	20 msec duration and 10 psi	8412
@NP	20 msec duration	8412
@NP	10 psi	8433
@NP	Picospritzer II	8441
@NP	General Valve , Fairfield , NJ	8458
@NP	General Valve	8458
@NP	Fairfield , NJ	8473
@NP	leakage	8500
@NP	the micropipette	8509
@NP	the spinal parenchyma 2 min	8543
@NP	the end of each injection	8577
@NP	the end	8577
@NP	each injection	8588
@NP	the wound	8613
@NP	5-0 silk thread in the muscular plane and small clips in the skin	8640
@NP	5-0 silk thread in the muscular plane	8640
@NP	5-0 silk thread	8640
@NP	the muscular plane	8659
@NP	small clips in the skin	8682
@NP	small clips	8682
@NP	the skin	8697
@NP	Rats	8723
@NP	a warm environment	8741
@NP	full recovery	8766
@NP	Animals	8781
@NP	two per cage	8801
@NP	two	8801
@NP	cage	8809
@NP	a 12 hr light/dark cycle	8831
@NP	free access	8865
@NP	food and water	8880
@NP	The experimental procedures	8896
@NP	the Ethics Committee of our institution	8941
@NP	the Ethics Committee	8941
@NP	our institution	8965
@NP	Neurological Evaluation All the neurological tests	8982
@NP	Neurological Evaluation	8982
@NP	All the neurological tests	9006
@NP	the operation	9055
@NP	7 , 14 , 21 , 30 , 60 , and 90 days postoperation -LRB- dpo -RRB-	9076
@NP	7	9076
@NP	14	9079
@NP	21	9083
@NP	30	9087
@NP	60	9091
@NP	90 days postoperation -LRB- dpo -RRB-	9099
@NP	90 days	9099
@NP	postoperation -LRB- dpo -RRB-	9107
@NP	postoperation	9107
@NP	dpo	9122
@NP	Locomotor behavior	9128
@NP	the open field test	9166
@NP	the BBB scale -LRB- Basso et al. , 1995 -RRB-	9200
@NP	the BBB scale	9200
@NP	Basso	9215
@NP	et al. , 1995	9221
@NP	et al.	9221
@NP	1995	9229
@NP	The animals	9236
@NP	a circular enclosure	9276
@NP	5 min	9328
@NP	Two independent examiners	9335
@NP	the hindlimb movements of the rat	9370
@NP	the hindlimb movements	9370
@NP	the rat	9396
@NP	the locomotor function	9415
@NP	the BBB scale	9451
@NP	0 -LRB- no movement -RRB-	9478
@NP	0	9478
@NP	no movement	9481
@NP	21 -LRB- normal movement -RRB-	9497
@NP	21	9497
@NP	normal movement	9501
@NP	The animal 's ability to maintain postural stability	9519
@NP	The animal 's	9519
@NP	postural stability	9552
@NP	the inclined plane test	9590
@NP	The rats	9615
@NP	the inclined plane	9639
@NP	the maximum inclination at which the rat could maintain its position for 5 sec	9663
@NP	the maximum inclination	9663
@NP	the rat	9696
@NP	its position	9719
@NP	5 sec	9736
@NP	the `` capacity angle '' -LRB- Rivlin et al. , 1977 -RRB-	9772
@NP	the `` capacity angle ''	9772
@NP	Rivlin	9794
@NP	et al. , 1977	9801
@NP	et al.	9801
@NP	1977	9809
@NP	Nociceptive sensibility	9816
@NP	a heatradiation method	9859
@NP	a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	9891
@NP	a plantar algesimeter	9891
@NP	Hargreaves	9914
@NP	et al. , 1988	9925
@NP	et al.	9925
@NP	1988	9933
@NP	The rats	9940
@NP	a plexiglass box on an elevated glass floor	9981
@NP	a plexiglass box	9981
@NP	an elevated glass floor	10001
@NP	A radiant heat stimulus	10026
@NP	a light beam	10074
@NP	the plantar surface of the hindpaw	10101
@NP	the plantar surface	10101
@NP	the hindpaw	10124
@NP	The time to withdrawal of the heated paw	10137
@NP	The time	10137
@NP	withdrawal of the heated paw	10149
@NP	withdrawal	10149
@NP	the heated paw	10163
@NP	a timemeter coupled with infrared detectors directed to the plantar surface	10199
@NP	a timemeter	10199
@NP	infrared detectors directed to the plantar surface	10224
@NP	infrared detectors	10224
@NP	the plantar surface	10255
@NP	The maximal time of stimulation	10276
@NP	The maximal time	10276
@NP	stimulation	10296
@NP	40 sec	10323
@NP	skin damage	10339
@NP	The value for a test	10352
@NP	The value	10352
@NP	a test	10366
@NP	the mean of three trials separated by 5-min resting periods	10377
@NP	the mean	10377
@NP	three trials separated by 5-min resting periods	10389
@NP	three trials	10389
@NP	5-min resting periods	10415
@NP	Electrophysiological Evaluation Electrophysiological tests	10438
@NP	both hindlimbs	10527
@NP	the injury	10549
@NP	14 , 30 , 60 , and 90 dpo	10567
@NP	14	10567
@NP	30	10571
@NP	60	10575
@NP	90 dpo	10583
@NP	The animals	10591
@NP	a warmed , flat coil	10662
@NP	a hot water circulating pump to maintain skin temperature above 32 Â°C	10696
@NP	a hot water	10696
@NP	pump	10720
@NP	skin temperature	10737
@NP	32 Â°C	10760
@NP	reproducibility	10776
@NP	all the electrophysiological tests	10795
@NP	the stimulation and recording needles	10831
@NP	microscopic magnification	10887
@NP	the same placement	10923
@NP	all animals , guided by anatomical landmarks	10945
@NP	all animals	10945
@NP	anatomical landmarks	10968
@NP	Central conduction studies	10990
@NP	the integrity of spinal cord	11044
@NP	the integrity	11044
@NP	spinal cord	11061
@NP	pathways	11098
@NP	Motor	11108
@NP	potentials -LRB- MEPs -RRB-	11121
@NP	potentials	11121
@NP	MEPs	11133
@NP	transcranial stimulation	11156
@NP	two needle electrodes	11186
@NP	the skull	11235
@NP	single electrical pulses of 25 mA intensity and 100 Âµsec duration	11257
@NP	single electrical pulses	11257
@NP	25 mA intensity and 100 Âµsec duration	11285
@NP	25 mA intensity	11285
@NP	100 Âµsec duration	11305
@NP	the tibialis	11342
@NP	anterior muscle -LRB- GarcÄ± ' a-AlÄ± ' as et al. , 2003 -RRB-	11355
@NP	anterior muscle	11355
@NP	GarcÄ± ' a-AlÄ± ' as et al. , 2003	11372
@NP	GarcÄ± '	11372
@NP	a-AlÄ± ' as et al. , 2003	11378
@NP	a-AlÄ±	11378
@NP	et al.	11387
@NP	2003	11395
@NP	The signals	11402
@NP	bandpass 1 -- 5,000 Hz	11440
@NP	bandpass 1	11440
@NP	5,000 Hz	11451
@NP	Sapphyre 4ME ; Vickers	11496
@NP	Sapphyre 4ME	11496
@NP	Vickers	11510
@NP	the latency	11530
@NP	onset	11545
@NP	the amplitude from onset	11555
@NP	the amplitude	11555
@NP	onset	11574
@NP	peak of the negative deflection	11583
@NP	peak	11583
@NP	the negative deflection	11591
@NP	reproducibility	11626
@NP	five consecutive responses	11643
@NP	a time interval of 30 sec between stimuli	11690
@NP	a time interval	11690
@NP	30 sec between stimuli	11709
@NP	30 sec	11709
@NP	stimuli	11724
@NP	the recording with the highest amplitude	11737
@NP	the recording	11737
@NP	the highest amplitude	11756
@NP	analysis	11791
@NP	Somatosensory	11801
@NP	potentials -LRB- SSEPs -RRB-	11822
@NP	potentials	11822
@NP	SSEPs	11834
@NP	stimuli -LRB- 3 mA , 100 Âµsec , at 6 Hz -RRB-	11867
@NP	stimuli	11867
@NP	3 mA , 100 Âµsec	11876
@NP	3 mA	11876
@NP	100 Âµsec	11882
@NP	6 Hz	11895
@NP	the tibial nerve at the ankle	11904
@NP	the tibial nerve	11904
@NP	the ankle	11924
@NP	The active recording needle electrode	11935
@NP	the contralateral sensorimotor area	12004
@NP	a reference electrode	12046
@NP	the base of the nose and a ground electrode at the base of the tail	12071
@NP	the base of the nose	12071
@NP	the base	12071
@NP	the nose	12083
@NP	a ground electrode at the base of the tail	12096
@NP	a ground electrode	12096
@NP	the base of the tail	12118
@NP	the base	12118
@NP	the tail	12130
@NP	total 256	12143
@NP	signals	12153
@NP	bandpass 20 -- 1,000 Hz	12187
@NP	bandpass 20	12187
@NP	1,000 Hz	12199
@NP	The latency and the peak-to-peak amplitude of the three main negative waves	12224
@NP	The latency	12224
@NP	the peak-to-peak amplitude of the three main negative waves	12240
@NP	the peak-to-peak amplitude	12240
@NP	the three main negative waves	12270
@NP	Nuwe , 1998 ; GarcÄ± ' a-AlÄ± ' as et al. , 2003	12315
@NP	Nuwe	12315
@NP	1998 ; GarcÄ± ' a-AlÄ± ' as et al. , 2003	12321
@NP	1998	12321
@NP	GarcÄ± ' a-AlÄ± ' as et al. , 2003	12327
@NP	GarcÄ± ' a-AlÄ±	12327
@NP	GarcÄ± '	12327
@NP	et al.	12342
@NP	2003	12350
@NP	Motor nerve conduction studies	12357
@NP	the lumbar H reflex	12415
@NP	The sciatic nerve	12436
@NP	single electrical pulses	12474
@NP	100 sec duration and supramaximal intensity	12500
@NP	100 sec duration	12500
@NP	supramaximal intensity	12522
@NP	monopolar needles inserted percutaneously at the sciatic notch	12559
@NP	monopolar needles	12559
@NP	the sciatic notch	12604
@NP	The compound muscle action potentials -LRB- CMAPs -RRB-	12623
@NP	The compound muscle action potentials	12623
@NP	CMAPs	12662
@NP	the tibialis anterior muscle	12672
@NP	means of needle electrodes	12718
@NP	means	12718
@NP	needle electrodes	12727
@NP	the oscilloscope	12762
@NP	The latency	12780
@NP	stimulus to negative peak	12797
@NP	stimulus	12797
@NP	negative peak	12809
@NP	the amplitude from onset to peak of the M and H waves	12827
@NP	the amplitude	12827
@NP	onset to peak of the M and H waves	12846
@NP	onset	12846
@NP	peak of the M and H waves	12855
@NP	peak	12855
@NP	the M and H waves	12863
@NP	Valero-Cabre ' and Navarro , 2002	12896
@NP	Valero-Cabre '	12896
@NP	Navarro , 2002	12914
@NP	Navarro	12914
@NP	2002	12923
@NP	The ratio of H/M maximal amplitudes	12930
@NP	The ratio	12930
@NP	H/M maximal amplitudes	12943
@NP	this	12982
@NP	an index	12996
@NP	the proportion	13008
@NP	motoneurons	13026
@NP	monosynaptic reflex relative to the total motoneuronal pool	13052
@NP	the total motoneuronal pool	13084
@NP	Thompson	13113
@NP	et al. , 1992	13122
@NP	et al.	13122
@NP	1992	13130
@NP	Anterograde Tracing of the Costicospinal Tract	13137
@NP	Anterograde Tracing	13137
@NP	the Costicospinal Tract	13160
@NP	the last electrophysiological evaluation	13190
@NP	the animals	13232
@NP	pentobarbital 40 mg/kg , i.p.	13263
@NP	pentobarbital 40 mg/kg	13263
@NP	pentobarbital	13263
@NP	40 mg/kg	13277
@NP	a stereotaxic frame	13307
@NP	A bilateral craniotomy centered at a point 2 mm lateral to Bregma	13328
@NP	A bilateral craniotomy	13328
@NP	a point 2 mm lateral to Bregma	13363
@NP	a point 2 mm lateral	13363
@NP	Bregma	13387
@NP	the dura	13404
@NP	a stab	13426
@NP	1.5 mm	13434
@NP	the sensorimotor cortex	13461
@NP	a fine forceps -LRB- Dumont No. 5 -RRB-	13491
@NP	a fine forceps	13491
@NP	Dumont No. 5	13507
@NP	Dumont No.	13507
@NP	5	13518
@NP	two to four DiI crystals	13522
@NP	D-3911 ; Molecular Probes Europe	13548
@NP	D-3911	13548
@NP	Molecular Probes Europe	13556
@NP	Leiden , The Netherlands	13581
@NP	Leiden	13581
@NP	The Netherlands	13589
@NP	the depth of the cortical incision	13625
@NP	the depth	13625
@NP	the cortical incision	13638
@NP	the cortical edges	13670
@NP	the crystals -LRB- Tsai et al. , 2001 -RRB-	13721
@NP	the crystals	13721
@NP	Tsai	13735
@NP	et al. , 2001	13740
@NP	et al.	13740
@NP	2001	13748
@NP	the skin	13764
@NP	Fifteen days	13802
@NP	DiI application	13821
@NP	rats	13838
@NP	4 % paraformaldehyde	13894
@NP	phosphatebuffered solution -LRB- PBS ; 0.1 M , pH 7.4 -RRB-	13917
@NP	phosphatebuffered solution	13917
@NP	PBS	13945
@NP	0.1 M , pH 7.4	13950
@NP	0.1 M	13950
@NP	pH 7.4	13957
@NP	The T1 , T8 , and T13 spinal cord segments	13966
@NP	The T1 , T8 , and T13	13966
@NP	spinal cord segments	13986
@NP	postfixed overnight in the same solution	14033
@NP	postfixed overnight	14033
@NP	the same solution	14056
@NP	a cryoprotection solution -LRB- 30 % sucrose in 0.1 MPBS -RRB-	14089
@NP	a cryoprotection solution	14089
@NP	30 % sucrose in 0.1 MPBS	14116
@NP	30 % sucrose	14116
@NP	0.1 MPBS	14131
@NP	4 Â°C	14143
@NP	a cryostat	14153
@NP	the spinal cord segments	14165
@NP	40-Âµm-thick transverse sections	14213
@NP	free-floating in De Olmos antifreeze buffer	14256
@NP	De Olmos	14273
@NP	Five intact control rats	14301
@NP	the same spinal cord segments	14376
@NP	group CNT	14448
@NP	Spinal cord sections	14460
@NP	PBS , mounted on gelatin-coated slides ,	14496
@NP	PBS	14496
@NP	gelatin-coated slides	14512
@NP	a fluorescent microscope -LRB- Olympus BX-51 -RRB-	14554
@NP	a fluorescent microscope	14554
@NP	Olympus BX-51	14580
@NP	appropriate filters -LRB- Tsai et al. , 2001 -RRB-	14600
@NP	appropriate filters	14600
@NP	Tsai	14621
@NP	et al. , 2001	14626
@NP	et al.	14626
@NP	2001	14634
@NP	Immunohistochemical Procedures Cryostat sections from the T8 segment	14641
@NP	Immunohistochemical Procedures Cryostat sections	14641
@NP	Immunohistochemical Procedures	14641
@NP	the T8 segment	14695
@NP	PBS with 0.3 % Triton X-100 -LRB- Fluka -RRB-	14741
@NP	PBS	14741
@NP	0.3 % Triton X-100 -LRB- Fluka -RRB-	14750
@NP	0.3 % Triton X-100	14750
@NP	Fluka	14769
@NP	1 % fetal calf serum -LRB- Biological Industries -RRB-	14780
@NP	1 %	14780
@NP	fetal calf serum -LRB- Biological Industries -RRB-	14783
@NP	fetal calf serum	14783
@NP	Biological Industries	14801
@NP	1 hr	14828
@NP	they	14840
@NP	rabbit antisera	14865
@NP	glial fibrillary acidic protein	14884
@NP	GFAP	14917
@NP	1:1,000 ; Chemicon , Temecula , CA	14923
@NP	1:1,000	14923
@NP	Chemicon , Temecula , CA	14932
@NP	mouse antisera	14957
@NP	nerve growth factor low-affinity receptor	14975
@NP	p75 ; 1:200 ; MAB365 ; Chemicon	15018
@NP	p75	15018
@NP	1:200 ; MAB365 ; Chemicon	15023
@NP	1:200	15023
@NP	MAB365 ; Chemicon	15030
@NP	MAB365	15030
@NP	Chemicon	15038
@NP	chondroitin sulfate clone CS-56 proteoglycan	15053
@NP	CSPG ; 1:50 ; C-8035 ; Sigma	15099
@NP	CSPG	15099
@NP	1:50 ; C-8035 ; Sigma	15105
@NP	1:50	15105
@NP	C-8035 ; Sigma	15111
@NP	C-8035	15111
@NP	Sigma	15119
@NP	48 hr at 4 Â°C	15130
@NP	48 hr	15130
@NP	4 Â°C	15139
@NP	several washes	15150
@NP	the sections	15166
@NP	secondary antisera	15199
@NP	donkey anti-rabbit	15219
@NP	goat anti-mouse Cy3-labeled immunoglobulin G	15241
@NP	1:200 ; Jackson Immunoresearch	15287
@NP	1:200	15287
@NP	Jackson Immunoresearch	15294
@NP	West Grove , PA	15318
@NP	West Grove	15318
@NP	PA	15330
@NP	overnight at 4 Â°C	15335
@NP	overnight	15335
@NP	4 Â°C	15348
@NP	additional washes	15359
@NP	sections	15378
@NP	gelatin-coated slides	15403
@NP	ethanol	15440
@NP	dextropropoxyphene -LRB- DPX ; Fluka -RRB-	15466
@NP	dextropropoxyphene	15466
@NP	DPX ; Fluka	15486
@NP	DPX	15486
@NP	Fluka	15491
@NP	antibody specificity	15514
@NP	some sections	15536
@NP	primary antisera	15589
@NP	The samples	15622
@NP	an Olympus BX-51 microscope	15652
@NP	epifluorescence	15694
@NP	appropriate filters	15716
@NP	the serotoninergic descending pathways from brainstem raphe nuclei	15750
@NP	the serotoninergic descending pathways	15750
@NP	brainstem raphe nuclei	15794
@NP	spinal cord sections from T13 segments	15818
@NP	spinal cord sections	15818
@NP	T13 segments	15844
@NP	serotonin -LRB- 5-HT ; 1:200 ; Diasorin , Stillwater , MN -RRB-	15884
@NP	serotonin	15884
@NP	5-HT ; 1:200 ; Diasorin , Stillwater , MN	15895
@NP	5-HT	15895
@NP	1:200 ; Diasorin , Stillwater , MN	15901
@NP	1:200	15901
@NP	Diasorin , Stillwater , MN	15908
@NP	Diasorin , Stillwater	15908
@NP	MN	15930
@NP	Low-magnification	15935
@NP	x4	15954
@NP	images of spinal cord sections	15958
@NP	images	15958
@NP	spinal cord sections	15968
@NP	the aid of a digital camera	16005
@NP	the aid	16005
@NP	a digital camera	16016
@NP	Olympus DP50	16034
@NP	the microscope	16060
@NP	NIH Image software	16094
@NP	GFAP-immunostained sections	16114
@NP	the preserved spinal cord parenchyma	16164
@NP	the lesion site -LRB- T8 -RRB-	16204
@NP	the lesion site	16204
@NP	T8	16221
@NP	strong immunostaining	16234
@NP	reactive astrocytes	16268
@NP	the destroyed parenchyma	16315
@NP	Two independent subjects	16341
@NP	these measurements	16371
@NP	the same images -LRB- 8 -- 10 sections for each animal -RRB-	16395
@NP	the same images	16395
@NP	8	16412
@NP	10 sections for each animal	16414
@NP	10 sections	16414
@NP	each animal	16430
@NP	the final area of preserved cord of each section analyzed	16448
@NP	the final area	16448
@NP	preserved cord of each section analyzed	16466
@NP	preserved cord	16466
@NP	each section analyzed	16484
@NP	each section	16484
@NP	the mean value of both subjects -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	16510
@NP	the mean value of	16510
@NP	the mean value	16510
@NP	subjects -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	16533
@NP	subjects	16533
@NP	Verdu ' et al. , 2001 , 2003b	16543
@NP	Verdu '	16543
@NP	et al. , 2001 , 2003b	16550
@NP	et al.	16550
@NP	2001	16558
@NP	2003b	16564
@NP	Confocal images of GFAP-immunostained sections from the lesion level	16572
@NP	Confocal images	16572
@NP	GFAP-immunostained sections from the lesion level	16591
@NP	GFAP-immunostained sections	16591
@NP	the lesion level	16624
@NP	T8	16642
@NP	the GFAP staining	16670
@NP	means	16692
@NP	a confocal imaging system -LRB- Leica TCS-4D -RRB-	16701
@NP	a confocal imaging system	16701
@NP	Leica TCS-4D	16728
@NP	images	16743
@NP	an area of 0.07 mm2	16763
@NP	an area	16763
@NP	0.07 mm2	16774
@NP	both ventral spinal cord horns of at least three sections per animal	16788
@NP	both ventral spinal cord horns	16788
@NP	at least three sections per animal	16822
@NP	at least three sections	16822
@NP	animal	16850
@NP	a total of six images per rat	16873
@NP	a total	16873
@NP	six images per rat	16884
@NP	six images	16884
@NP	rat	16899
@NP	a x40 lens	16910
@NP	The grade of GFAP immunostaining	16922
@NP	The grade	16922
@NP	GFAP immunostaining	16935
@NP	the method described by AcarÄ± 'n et al. -LRB- 1997 -RRB-	16973
@NP	the method	16973
@NP	AcarÄ± 'n et al. -LRB- 1997 -RRB-	16997
@NP	AcarÄ±	16997
@NP	et al.	17005
@NP	1997	17013
@NP	The measurement , referred to as the `` reactive grade , ''	17020
@NP	The measurement	17020
@NP	the `` reactive grade	17052
@NP	the ratio between immunolabeling density	17089
@NP	the ratio	17089
@NP	immunolabeling density	17107
@NP	spinal cord sections of injured animals vs. unlesioned rats	17133
@NP	spinal cord sections	17133
@NP	injured animals vs. unlesioned rats	17157
@NP	injured animals	17157
@NP	unlesioned rats	17177
@NP	Spinal cord sections immunolabeled against CSPG	17194
@NP	Spinal cord sections	17194
@NP	CSPG	17237
@NP	the intensity of CSPG fluorescence	17266
@NP	the intensity	17266
@NP	CSPG fluorescence	17283
@NP	a method similar to that described by Plant et al. -LRB- 2001 -RRB-	17304
@NP	a method	17304
@NP	that described by Plant et al. -LRB- 2001 -RRB-	17324
@NP	that	17324
@NP	Plant	17342
@NP	et al. -LRB- 2001 -RRB-	17348
@NP	et al.	17348
@NP	2001	17356
@NP	Spinal cord images -LRB- x4 -RRB-	17363
@NP	Spinal cord images	17363
@NP	x4	17383
@NP	NIH Image software	17407
@NP	Fluorescence intensity	17427
@NP	a scale	17460
@NP	0 -LRB- maximal fluorescence -RRB- and 250 -LRB- no fluorescence -RRB-	17476
@NP	0	17476
@NP	maximal fluorescence	17479
@NP	250	17505
@NP	no fluorescence	17510
@NP	At least eight sections per animal	17528
@NP	At least eight sections	17528
@NP	animal	17556
@NP	Statistical Analysis All neurological	17592
@NP	Statistical Analysis	17592
@NP	All neurological	17613
@NP	electrophysiological , and histological measurements	17631
@NP	a blinded manner	17701
@NP	A code for rats and histological slices	17719
@NP	A code	17719
@NP	rats and histological slices	17730
@NP	rats	17730
@NP	histological slices	17739
@NP	Data	17769
@NP	the mean	17787
@NP	SEM , and electrophysiological	17799
@NP	SEM	17799
@NP	electrophysiological	17808
@NP	results	17829
@NP	the percentage with respect	17854
@NP	the percentage	17854
@NP	respect	17874
@NP	preoperative values for each rat	17885
@NP	preoperative values	17885
@NP	each rat	17909
@NP	Statistical comparisons between groups	17919
@NP	Statistical comparisons	17919
@NP	groups	17951
@NP	Kruskal-Wallis and Mann-Whitney U-tests	17973
@NP	Differences	18014
@NP	P < .05	18057
@NP	P	18057
@NP	.05	18061
@NP	RESULTS	18067
@NP	1	18080
@NP	Evolution of the open field locomotor activity	18083
@NP	Evolution	18083
@NP	the open field locomotor activity	18096
@NP	the BBB scale -LRB- A -RRB-	18143
@NP	the BBB scale	18143
@NP	A	18158
@NP	the maximum angle in the inclined plane test -LRB- B -RRB-	18162
@NP	the maximum angle	18162
@NP	the inclined plane test -LRB- B -RRB-	18183
@NP	the inclined plane test	18183
@NP	B	18208
@NP	the time	18216
@NP	withdrawal of the heated paw in the plantar algesimetry test over time	18228
@NP	withdrawal	18228
@NP	the heated paw in the plantar algesimetry test over time	18242
@NP	the heated paw	18242
@NP	the plantar algesimetry test over time	18260
@NP	the plantar algesimetry test	18260
@NP	time	18294
@NP	photochemical injury	18305
@NP	the spinal cord -LRB- C -RRB-	18329
@NP	the spinal cord	18329
@NP	C	18346
@NP	P <	18351
@NP	P	18351
@NP	<	18353
@NP	.05 vs. group DM .	18355
@NP	.05	18355
@NP	group DM .	18363
@NP	group	18363
@NP	Fig. 2 .	18374
@NP	Fig.	18374
@NP	2	18379
@NP	Representative electrophysiological recordings of motor	18382
@NP	Representative electrophysiological recordings	18382
@NP	motor	18432
@NP	potentials -LRB- A -- D -RRB-	18445
@NP	potentials	18445
@NP	A -- D	18457
@NP	A	18457
@NP	D	18459
@NP	somatosensory evoked potentials -LRB- E -- H -RRB-	18463
@NP	somatosensory evoked potentials	18463
@NP	E -- H	18496
@NP	E	18496
@NP	H	18498
@NP	compound muscle action potentials -LRB- I -- L -RRB-	18506
@NP	compound muscle action potentials	18506
@NP	I -- L	18541
@NP	I	18541
@NP	L	18543
@NP	an animal prior to injury -LRB- A , E , I -RRB-	18551
@NP	an animal prior to injury	18551
@NP	an animal	18551
@NP	injury	18570
@NP	A	18578
@NP	E	18580
@NP	I	18582
@NP	rats	18594
@NP	group OEC -LRB- B , F , J -RRB-	18602
@NP	group OEC	18602
@NP	B , F , J	18613
@NP	group SC -LRB- C , G , K -RRB-	18621
@NP	group SC	18621
@NP	C , G , K	18631
@NP	group DM -LRB- D , H , L -RRB-	18643
@NP	group DM	18643
@NP	D , H , L	18653
@NP	90 dpo	18663
@NP	Horizontal bar	18671
@NP	= 5 msec , vertical bar = 5 mV for A -- D ; horizontal bar = 10	18686
@NP	= 5 msec , vertical bar = 5 mV	18686
@NP	5 msec , vertical bar	18688
@NP	5 msec	18688
@NP	vertical bar	18696
@NP	5	18711
@NP	A -- D ; horizontal bar = 10	18720
@NP	A -- D ; horizontal bar	18720
@NP	D	18722
@NP	10	18742
@NP	msec , vertical bar	18745
@NP	= 4 ÂµV for E	18764
@NP	= 4 ÂµV	18764
@NP	4	18766
@NP	E	18775
@NP	H ; horizontal bar = 2 msec , vertical bar = 10 mV for I -- L.	18777
@NP	H	18777
@NP	horizontal bar = 2 msec , vertical bar = 10 mV for I	18780
@NP	horizontal bar	18780
@NP	= 2 msec , vertical bar = 10 mV for I	18795
@NP	= 2 msec , vertical bar = 10 mV	18795
@NP	2 msec , vertical bar	18797
@NP	2 msec	18797
@NP	vertical bar	18805
@NP	10	18820
@NP	I	18830
@NP	L.	18832
@NP	Fig. 3 .	18836
@NP	Fig.	18836
@NP	3	18841
@NP	Mean percentage	18844
@NP	the amplitudes of the MEP -LRB- A -RRB- and the N1 wave -LRB- B -RRB-	18863
@NP	the amplitudes	18863
@NP	the MEP -LRB- A -RRB- and the N1 wave -LRB- B -RRB-	18881
@NP	the MEP	18881
@NP	A	18890
@NP	the N1 wave	18897
@NP	B	18910
@NP	the SSEP tests	18925
@NP	respect	18945
@NP	preoperative values of each animal though the 3-month follow-up	18956
@NP	preoperative values	18956
@NP	each animal though the 3-month follow-up	18979
@NP	each animal	18979
@NP	the 3-month follow-up	18998
@NP	P <	19022
@NP	P	19022
@NP	<	19024
@NP	.05 vs. group DM .	19026
@NP	.05	19026
@NP	group DM .	19034
@NP	group	19034
@NP	Fig. 4 .	19045
@NP	Fig.	19045
@NP	4	19050
@NP	Mean percentage	19053
@NP	the amplitudes of the M wave -LRB- A -RRB- and the H/M ratio -LRB- B -RRB-	19072
@NP	the amplitudes	19072
@NP	the M wave -LRB- A -RRB- and the H/M ratio -LRB- B -RRB-	19090
@NP	the M wave	19090
@NP	A	19102
@NP	the H/M ratio	19109
@NP	B	19124
@NP	motor nerve conduction tests with respect	19139
@NP	motor nerve conduction tests	19139
@NP	respect	19173
@NP	preoperative values from each animal	19184
@NP	preoperative values	19184
@NP	each animal	19209
@NP	the 3-month followup	19229
@NP	Fig. 5 .	19252
@NP	Fig.	19252
@NP	5	19257
@NP	Spinal cord sections	19260
@NP	GFAP -LRB- A -- C -RRB- and CSPG -LRB- D -- F -RRB-	19303
@NP	GFAP	19303
@NP	A -- C	19309
@NP	A	19309
@NP	C	19311
@NP	CSPG	19318
@NP	D -- F	19324
@NP	D	19324
@NP	F	19326
@NP	the lesion site	19338
@NP	animals	19359
@NP	group OEC -LRB- A , D -RRB-	19370
@NP	group OEC	19370
@NP	A , D	19381
@NP	A	19381
@NP	D	19383
@NP	group SC -LRB- B , E -RRB-	19387
@NP	group SC	19387
@NP	B , E	19397
@NP	B	19397
@NP	E	19399
@NP	group DM -LRB- C , F -RRB-	19407
@NP	group DM	19407
@NP	C , F	19417
@NP	C	19417
@NP	F	19419
@NP	Glial grafts	19423
@NP	sparing of the injured dorsolateral areas of the spinal cord	19444
@NP	sparing	19444
@NP	the injured dorsolateral areas of the spinal cord	19455
@NP	the injured dorsolateral areas	19455
@NP	the spinal cord	19489
@NP	Fig. 6 .	19507
@NP	Fig.	19507
@NP	6	19512
@NP	Spinal cord sections at T13 showing the dorsal corticospinal tract	19515
@NP	Spinal cord sections	19515
@NP	T13 showing the dorsal corticospinal tract	19539
@NP	T13	19539
@NP	the dorsal corticospinal tract	19551
@NP	DiI	19595
@NP	rats	19602
@NP	group OEC -LRB- A -RRB- , group SC -LRB- B -RRB- , and group DM -LRB- C -RRB-	19610
@NP	group OEC -LRB- A -RRB-	19610
@NP	group OEC	19610
@NP	A	19621
@NP	group SC -LRB- B -RRB-	19625
@NP	group SC	19625
@NP	B	19635
@NP	group DM -LRB- C -RRB-	19643
@NP	group DM	19643
@NP	C	19653
@NP	Spinal cord section at T13	19657
@NP	Spinal cord section	19657
@NP	T13	19680
@NP	5-HT	19706
@NP	rats	19716
@NP	group OEC -LRB- D -RRB- , group SC -LRB- E -RRB- , and group DM -LRB- F -RRB-	19724
@NP	group OEC -LRB- D -RRB-	19724
@NP	group OEC	19724
@NP	D	19735
@NP	group SC -LRB- E -RRB-	19739
@NP	group SC	19739
@NP	E	19749
@NP	group DM -LRB- F -RRB-	19757
@NP	group DM	19757
@NP	F	19767
@NP	spinal cord injury	19778
@NP	no signs of infection or bladder dysfunction	19798
@NP	no signs	19798
@NP	infection or bladder dysfunction	19810
@NP	The body weight of the animals	19855
@NP	The body weight	19855
@NP	the animals	19874
@NP	time	19901
@NP	the end of the evaluation	19915
@NP	the end	19915
@NP	the evaluation	19926
@NP	weights	19942
@NP	124 % Â± 4 % , 127 % Â± 3 % , and 117 % Â± 9 %	19964
@NP	124 % Â± 4 %	19964
@NP	124 %	19964
@NP	Â± 4 %	19969
@NP	127 % Â± 3 %	19975
@NP	127 %	19975
@NP	Â± 3 %	19980
@NP	117 % Â± 9 %	19990
@NP	117 %	19990
@NP	Â± 9 %	19995
@NP	the OEC , SC , and DM groups	20003
@NP	the OEC	20003
@NP	SC	20012
@NP	DM groups	20020
@NP	Functional Results	20045
@NP	7 dpo	20067
@NP	the animals of all the groups	20074
@NP	the animals	20074
@NP	all the groups	20089
@NP	moderate locomotor deficits	20114
@NP	Rats of the OEC and SC groups	20143
@NP	Rats	20143
@NP	the OEC and SC groups	20151
@NP	irregularity of fine details of locomotion	20220
@NP	irregularity	20220
@NP	fine details of locomotion	20236
@NP	fine details	20236
@NP	locomotion	20252
@NP	16	20272
@NP	Â± 1 and 18 Â± 0.5 , respectively	20275
@NP	Â± 1 and 18 Â± 0.5	20275
@NP	DM animals	20315
@NP	gross locomotion	20330
@NP	unbalanced stepping	20352
@NP	unbalanced	20352
@NP	a mean score of 10 Â± 1	20376
@NP	a mean score	20376
@NP	10 Â± 1	20392
@NP	P < .05 with respect to groups OEC and SC ; Fig. 1A	20400
@NP	P	20400
@NP	.05	20404
@NP	respect	20413
@NP	groups OEC and SC ; Fig. 1A	20424
@NP	groups	20424
@NP	OEC and SC	20431
@NP	Fig. 1A	20443
@NP	All the animals	20453
@NP	gradual improvement	20479
@NP	hindlimb locomotion	20502
@NP	90 dpo mean scores of 19 Â± 0.5 , 19 Â± 0.7 , and 15 Â± 2	20535
@NP	90 dpo mean scores of 19 Â± 0.5	20535
@NP	90 dpo mean scores	20535
@NP	19 Â± 0.5	20557
@NP	19 Â± 0.7	20567
@NP	19 Â±	20567
@NP	0.7	20572
@NP	15 Â± 2	20581
@NP	15 Â±	20581
@NP	2	20586
@NP	OEC , SC , and DM groups	20591
@NP	SC-grafted animals	20638
@NP	fluidity and velocity	20664
@NP	fluidity	20664
@NP	velocity	20677
@NP	their movements	20689
@NP	mild residual deficits	20725
@NP	animals from group DM	20757
@NP	animals	20757
@NP	group DM	20770
@NP	stability and balanced locomotion	20789
@NP	stability	20789
@NP	balanced locomotion	20803
@NP	No significant differences	20824
@NP	the end of follow-up -LRB- Fig. 1A -RRB-	20865
@NP	the end	20865
@NP	follow-up -LRB- Fig. 1A -RRB-	20876
@NP	follow-up	20876
@NP	Fig. 1A	20887
@NP	The mean values	20897
@NP	the capacity angle for each experimental group along follow-up	20916
@NP	the capacity angle	20916
@NP	each experimental group along follow-up	20939
@NP	each experimental group	20939
@NP	follow-up	20969
@NP	Figure 1B	20992
@NP	7 dpo	21006
@NP	the mean capacity angle values	21012
@NP	respect	21058
@NP	preoperative values	21069
@NP	40 Â± 0.9 , 41 Â± 0.5 , and 36 Â± 1.6 , in OEC , SC , and DM groups , respectively	21098
@NP	40 Â± 0.9	21098
@NP	40 Â±	21098
@NP	0.9	21103
@NP	41 Â± 0.5 , and 36 Â± 1.6 , in OEC , SC ,	21108
@NP	41	21108
@NP	Â± 0.5 , and 36 Â± 1.6 , in OEC , SC ,	21111
@NP	Â± 0.5	21111
@NP	36 Â± 1.6	21122
@NP	36	21122
@NP	Â± 1.6	21125
@NP	OEC , SC	21135
@NP	DM groups , respectively	21148
@NP	DM groups	21148
@NP	Significant differences	21173
@NP	group DM and the two transplanted groups	21216
@NP	group DM	21216
@NP	the two transplanted groups	21229
@NP	time	21263
@NP	the animals	21269
@NP	their ability to maintain stances at higher angles	21300
@NP	stances	21326
@NP	higher angles	21337
@NP	significant differences between groups -LRB- Fig. 1B -RRB-	21360
@NP	significant differences	21360
@NP	groups -LRB- Fig. 1B -RRB-	21392
@NP	groups	21392
@NP	Fig. 1B	21400
@NP	Withdrawal latencies obtained with the plantar algesimeter test	21410
@NP	Withdrawal latencies	21410
@NP	the plantar algesimeter test	21445
@NP	between 14 and 16 sec in preoperative controls	21481
@NP	between 14 and 16 sec	21481
@NP	preoperative controls	21506
@NP	injury	21535
@NP	limb withdrawal	21543
@NP	higher temperatures	21571
@NP	longer latencies	21611
@NP	90 dpo	21632
@NP	the mean withdrawal latencies	21639
@NP	19 Â± 1 , 18 Â± 1 , and 23 Â± 2	21674
@NP	19 Â± 1	21674
@NP	19 Â±	21674
@NP	1	21679
@NP	18 Â± 1	21682
@NP	18 Â±	21682
@NP	1	21687
@NP	23 Â± 2	21694
@NP	23 Â±	21694
@NP	2	21699
@NP	OEC , SC , and DM groups	21704
@NP	Significant differences	21742
@NP	group DM and the glia-transplanted groups	21785
@NP	group DM	21785
@NP	the glia-transplanted groups	21798
@NP	the follow-up -LRB- Fig. 1C -RRB-	21838
@NP	the follow-up	21838
@NP	Fig. 1C	21853
@NP	Electrophysiological Results	21863
@NP	The MEP	21892
@NP	baseline recordings on the tibialis anterior muscle	21900
@NP	baseline recordings	21900
@NP	the tibialis anterior muscle	21923
@NP	a short-latency	21965
@NP	negative deflection signal with an amplitude between 14	21982
@NP	negative deflection signal	21982
@NP	an amplitude between 14	22014
@NP	an amplitude	22014
@NP	14	22035
@NP	20 mV and an onset latency	22042
@NP	20 mV	22042
@NP	an onset latency	22052
@NP	6 msec	22078
@NP	Fig. 2A	22086
@NP	No changes in latency	22096
@NP	No changes	22096
@NP	latency	22110
@NP	spinal cord injury in any experimental group	22138
@NP	spinal cord injury	22138
@NP	any experimental group	22160
@NP	14 dpo	22187
@NP	the amplitudes of MEPs	22194
@NP	the amplitudes	22194
@NP	MEPs	22212
@NP	80 % , 79 % , and 7 % with respect	22228
@NP	80 %	22228
@NP	79 %	22233
@NP	7 % with respect	22242
@NP	7 %	22242
@NP	respect	22250
@NP	preoperative values in OEC , SC , and DM groups	22261
@NP	preoperative values	22261
@NP	OEC , SC , and DM groups	22284
@NP	follow-up	22329
@NP	the amplitude of MEPs increased in group OEC ,	22339
@NP	the amplitude	22339
@NP	MEPs increased in group OEC	22356
@NP	MEPs	22356
@NP	group OEC	22374
@NP	group SC	22407
@NP	group DM	22443
@NP	90 dpo	22456
@NP	the mean percentage amplitudes	22464
@NP	109 % , 63 % , and 0.1 % , in OEC , SC , and DM groups , respectively	22500
@NP	109 %	22500
@NP	63 % , and 0.1 % , in OEC , SC , and DM groups	22506
@NP	63 % , and 0.1 % ,	22506
@NP	63 %	22506
@NP	0.1 %	22515
@NP	OEC , SC , and DM groups	22524
@NP	Figs. 2B	22562
@NP	D , 3A	22571
@NP	D	22571
@NP	3A	22574
@NP	group DM	22608
@NP	the other two groups	22625
@NP	the preoperative tests	22650
@NP	the SSEPs	22674
@NP	a sequence of negative and positive peaks -LRB- Fig. 2E -RRB-	22697
@NP	a sequence	22697
@NP	negative and positive peaks -LRB- Fig. 2E -RRB-	22711
@NP	negative and positive peaks	22711
@NP	Fig. 2E	22740
@NP	Three complexes of negative peaks , N1 , N2 , and N3 ,	22750
@NP	Three complexes	22750
@NP	negative peaks , N1 , N2 , and N3 ,	22769
@NP	negative peaks	22769
@NP	N1 , N2 , and N3 ,	22785
@NP	all the animals	22831
@NP	injury	22854
@NP	no changes in the latency of the SSEP complexes	22862
@NP	no changes	22862
@NP	the latency of the SSEP complexes	22876
@NP	the latency	22876
@NP	the SSEP complexes	22891
@NP	the amplitude of all three complexes	22933
@NP	the amplitude	22933
@NP	all three complexes	22950
@NP	respect	22985
@NP	preoperative values	22996
@NP	the N1 wave being the most affected -LRB- Figs. 2F -- H , 3B -RRB-	23017
@NP	the N1 wave	23017
@NP	the most affected	23035
@NP	Figs. 2F	23054
@NP	H , 3B	23063
@NP	H	23063
@NP	3B	23066
@NP	follow-up	23079
@NP	the amplitude of the three peaks	23090
@NP	the amplitude	23090
@NP	the three peaks	23107
@NP	group DM rats	23146
@NP	it	23169
@NP	OEC and SC animals	23195
@NP	Significant differences	23215
@NP	the DM group and the SC and OEC groups	23258
@NP	the DM group	23258
@NP	the SC and OEC groups	23275
@NP	Electrical stimulation of the sciatic nerve	23298
@NP	Electrical stimulation	23298
@NP	the sciatic nerve	23324
@NP	rise to two negative deflections , the direct M wave and the late H	23347
@NP	rise	23347
@NP	two negative deflections , the direct M wave and the late H	23355
@NP	two negative deflections	23355
@NP	the direct M wave	23381
@NP	the late H	23403
@NP	reflex wave , recorded in the tibialis anterior muscle -LRB- Fig. 2I -RRB-	23414
@NP	reflex wave	23414
@NP	the tibialis anterior muscle -LRB- Fig. 2I -RRB-	23439
@NP	the tibialis anterior muscle	23439
@NP	Fig. 2I	23469
@NP	thoracic spinal cord injury	23485
@NP	the M wave latency and amplitude	23514
@NP	the M wave latency	23514
@NP	amplitude	23537
@NP	90 dpo in all the animals -LRB- Fig. 4A -RRB-	23580
@NP	90 dpo	23580
@NP	all the animals -LRB- Fig. 4A -RRB-	23590
@NP	all the animals	23590
@NP	Fig. 4A	23607
@NP	contrast	23620
@NP	the amplitude of the H wave	23630
@NP	the amplitude	23630
@NP	the H wave	23647
@NP	Fig. 2J -- L	23678
@NP	Fig. 2J	23678
@NP	L	23686
@NP	consequence	23697
@NP	the H/M ratio increased after injury	23709
@NP	the H/M ratio	23709
@NP	injury	23739
@NP	The increase in the H/M ratio	23747
@NP	The increase	23747
@NP	the H/M ratio	23763
@NP	time in the control DM group	23807
@NP	time	23807
@NP	the control DM group	23815
@NP	it	23845
@NP	preoperative values	23882
@NP	the OEC and SC groups -LRB- Fig. 4B -RRB-	23905
@NP	the OEC and SC groups	23905
@NP	Fig. 4B	23928
@NP	no significant differences	23947
@NP	the large interindividual variability	23996
@NP	Immunohistochemical Results	24035
@NP	Transverse sections	24063
@NP	the T8	24086
@NP	spinal cord segments of the DM animals	24093
@NP	spinal cord segments	24093
@NP	the DM animals	24117
@NP	the photochemical injury	24144
@NP	a cavity	24178
@NP	the dorsal aspect of the spinal cord	24210
@NP	the dorsal aspect	24210
@NP	the spinal cord	24231
@NP	the dorsal funiculus and the dorsal and middle aspects of the lateral funiculi	24258
@NP	the dorsal funiculus and the dorsal	24258
@NP	the dorsal funiculus	24258
@NP	the dorsal	24283
@NP	middle aspects of the lateral funiculi	24298
@NP	middle aspects	24298
@NP	the lateral funiculi	24316
@NP	Verdu	24363
@NP	'	24368
@NP	et al. , 2003a	24370
@NP	et al.	24370
@NP	2003a	24378
@NP	The cavity	24386
@NP	scar tissue , strongly immunostained with anti-GFAP	24415
@NP	scar tissue	24415
@NP	anti-GFAP	24456
@NP	The OEC - and SC-transplanted animals	24467
@NP	The OEC	24467
@NP	SC-transplanted animals	24480
@NP	an open cavity	24514
@NP	the dorsal aspect of the spinal cord	24532
@NP	the dorsal aspect	24532
@NP	the spinal cord	24553
@NP	a lesser extension than that in the nontransplanted DM group	24579
@NP	a lesser extension	24579
@NP	that in the nontransplanted DM group	24603
@NP	that	24603
@NP	the nontransplanted DM group	24611
@NP	partial preservation of the dorsolateral funiculi -LRB- Fig. 5A -- C -RRB-	24646
@NP	partial preservation	24646
@NP	the dorsolateral funiculi -LRB- Fig. 5A -- C -RRB-	24670
@NP	the dorsolateral funiculi	24670
@NP	Fig. 5A -- C	24697
@NP	Fig. 5A	24697
@NP	C	24705
@NP	The average area of preserved spinal cord parenchyma	24709
@NP	The average area	24709
@NP	preserved spinal cord parenchyma	24729
@NP	0.15 mm2 in group OEC	24773
@NP	0.15 mm2	24773
@NP	group OEC	24785
@NP	2.97 Â±	24799
@NP	0.22 mm2	24806
@NP	group SC	24818
@NP	the 2.50	24859
@NP	Â± 0.22 mm2	24868
@NP	group DM	24888
@NP	Hypertrophied astrocytes , heavily stained for GFAP ,	24898
@NP	Hypertrophied astrocytes	24898
@NP	GFAP	24944
@NP	the spinal cord parenchyma	24966
@NP	the SC and DM groups	24997
@NP	these astrocytes	25019
@NP	longer and thicker processes than the OEC animals	25040
@NP	thicker processes than the OEC	25051
@NP	thicker processes	25051
@NP	the OEC	25074
@NP	The reactive grade of GFAP	25091
@NP	The reactive grade	25091
@NP	GFAP	25113
@NP	group OEC -LRB- 17.9 Â± 5.6 -RRB-	25145
@NP	group OEC	25145
@NP	17.9 Â± 5.6	25156
@NP	17.9 Â±	25156
@NP	5.6	25163
@NP	group SC -LRB- 28.8 Â± 4.4 -RRB-	25176
@NP	group SC	25176
@NP	28.8 Â± 4.4	25186
@NP	28.8 Â±	25186
@NP	4.4	25193
@NP	group DM -LRB- 28.6 Â± 2.2 -RRB-	25205
@NP	group DM	25205
@NP	28.6 Â± 2.2	25215
@NP	28.6	25215
@NP	Â± 2.2	25220
@NP	the lesion site	25231
@NP	CSPG immunostaining	25248
@NP	cord sections of all the experimental groups	25280
@NP	cord sections	25280
@NP	all the experimental groups	25297
@NP	The strongest labeling	25326
@NP	the cavity -LRB- Fig. 5D -- F -RRB-	25371
@NP	the cavity	25371
@NP	Fig. 5D -- F	25383
@NP	Fig. 5D	25383
@NP	F	25391
@NP	The immunostaining intensities	25395
@NP	189.7 Â± 17.7 , 177.7 Â± 8.6 , and 158.8 Â± 11.5 in groups OEC , SC , and DM	25431
@NP	189.7 Â± 17.7	25431
@NP	189.7	25431
@NP	Â± 17.7	25437
@NP	177.7 Â± 8.6	25445
@NP	177.7 Â±	25445
@NP	8.6	25453
@NP	158.8 Â± 11.5 in groups OEC , SC , and DM	25462
@NP	158.8 Â± 11.5 in groups OEC , SC ,	25462
@NP	158.8 Â± 11.5	25462
@NP	groups OEC , SC ,	25478
@NP	DM	25498
@NP	Significant differences	25516
@NP	group DM and the other two groups -LRB- P < .05 -RRB-	25559
@NP	group DM	25559
@NP	the other two groups -LRB- P < .05 -RRB-	25572
@NP	the other two groups	25572
@NP	P < .05	25594
@NP	P	25594
@NP	< .05	25596
@NP	<	25596
@NP	.05	25598
@NP	addition	25607
@NP	p75-positive cells	25617
@NP	spinal cord sections	25649
@NP	all the injured rats	25675
@NP	a dense meshwork	25705
@NP	the dorsal area	25729
@NP	No p75-positive cells	25746
@NP	ventral areas of the injured spinal cord	25791
@NP	ventral areas	25791
@NP	the injured spinal cord	25808
@NP	Some of the p75-positive cells	25833
@NP	Some	25833
@NP	the p75-positive cells	25841
@NP	a spherical morphology	25868
@NP	others	25900
@NP	a long , bipolar morphology	25915
@NP	large and thin or thick processes	25948
@NP	more p75 cells	25998
@NP	glia-transplanted groups	26027
@NP	group DM	26060
@NP	transverse spinal cord sections at T13	26072
@NP	transverse spinal cord sections	26072
@NP	T13	26107
@NP	serotonin fibers	26112
@NP	the lateral and ventral gray matter	26142
@NP	the white matter tracts	26185
@NP	This pattern	26210
@NP	the spinal cord sections of all groups -LRB- Fig. 6D -- F -RRB-	26238
@NP	the spinal cord sections	26238
@NP	all groups -LRB- Fig. 6D -- F -RRB-	26266
@NP	all groups	26266
@NP	Fig. 6D -- F	26278
@NP	Fig. 6D	26278
@NP	F	26286
@NP	Anterograde Tracing of the Costicospinal Tract	26290
@NP	Anterograde Tracing	26290
@NP	the Costicospinal Tract	26313
@NP	spinal cord sections taken at the T1 level from all rats	26340
@NP	spinal cord sections	26340
@NP	the T1 level	26370
@NP	all rats	26388
@NP	strong DiI staining	26398
@NP	the ventral aspect of the dorsal columns	26430
@NP	the ventral aspect	26430
@NP	the dorsal columns	26452
@NP	the corticospinal tract	26489
@NP	contrast	26517
@NP	the T13 spinal cord segment	26530
@NP	DiI staining	26559
@NP	spinal cord sections	26584
@NP	only three of eight rats of group OEC	26610
@NP	only three	26610
@NP	eight rats of group OEC	26624
@NP	eight rats	26624
@NP	group OEC	26638
@NP	none of groups SC and DM -LRB- Fig. 6A -- C -RRB-	26655
@NP	none	26655
@NP	groups SC and DM -LRB- Fig. 6A -- C -RRB-	26663
@NP	groups SC and DM	26663
@NP	Fig. 6A -- C	26681
@NP	Fig. 6A	26681
@NP	C	26689
@NP	DISCUSSION	26694
@NP	The results of this study	26705
@NP	The results	26705
@NP	this study	26720
@NP	acute transplantation of OECs or SCs	26741
@NP	acute transplantation	26741
@NP	OECs or SCs	26766
@NP	neuroprotective effects	26785
@NP	the spinal cord parenchyma of animals	26812
@NP	the spinal cord parenchyma	26812
@NP	animals	26842
@NP	photochemical injury of the thoracic spinal cord	26863
@NP	photochemical injury	26863
@NP	the thoracic spinal cord	26887
@NP	agreement with the increased tissue preservation	26916
@NP	agreement	26916
@NP	the increased tissue preservation	26931
@NP	better restoration of behavioral skills	26966
@NP	better restoration	26966
@NP	behavioral skills	26988
@NP	OEC - and SCtransplanted rats	27022
@NP	control DM rats	27059
@NP	the animals with OEC transplantation	27089
@NP	the animals	27089
@NP	OEC transplantation	27106
@NP	a better electrophysiological outcome	27136
@NP	SC - and DM-injected animals	27179
@NP	The histological results	27208
@NP	reduced glial reactivity and CSPG expression	27240
@NP	the site of injury in the OEC animals	27288
@NP	the site	27288
@NP	injury in the OEC animals	27300
@NP	injury	27300
@NP	the OEC animals	27310
@NP	SC and DM animals	27340
@NP	The mild photochemical lesion	27359
@NP	illumination for 2.5 min ; see Verdu ' et al. , 2003a	27390
@NP	illumination	27390
@NP	2.5 min ; see Verdu ' et al. , 2003a	27407
@NP	2.5 min	27407
@NP	Verdu ' et al. , 2003a	27420
@NP	Verdu ' et al.	27420
@NP	Verdu '	27420
@NP	et al.	27427
@NP	2003a	27435
@NP	the dorsal and lateral funiculi	27461
@NP	the dorsal	27461
@NP	lateral funiculi	27476
@NP	the dorsal horns	27497
@NP	the ventral and ventrolateral funiculi and ventral horn gray matter	27523
@NP	the ventral and ventrolateral funiculi	27523
@NP	ventral horn gray matter	27566
@NP	The locomotor function in control	27612
@NP	The locomotor function	27612
@NP	control	27638
@NP	injured rats was mildly involved	27646
@NP	injured rats	27646
@NP	scores 15 -- 16 on the BBB scale	27680
@NP	scores	27680
@NP	15 -- 16 on the BBB scale	27687
@NP	15 -- 16	27687
@NP	the BBB scale	27696
@NP	It	27712
@NP	lesions of the ventrolateral funiculus but not of the dorsal funiculus	27735
@NP	lesions	27735
@NP	the ventrolateral funiculus	27746
@NP	the dorsal funiculus	27785
@NP	severe locomotion deficits	27814
@NP	poor scores in the open field test -LRB- Schut et al. , 2002 -RRB-	27855
@NP	poor scores	27855
@NP	the open field test -LRB- Schut et al. , 2002 -RRB-	27870
@NP	the open field test	27870
@NP	Schut	27891
@NP	et al. , 2002	27897
@NP	et al.	27897
@NP	2002	27905
@NP	a result of the increased sparing of lateral funiculi	27915
@NP	a result	27915
@NP	the increased sparing of lateral funiculi	27927
@NP	the increased sparing	27927
@NP	lateral funiculi	27952
@NP	cell grafts	27980
@NP	the transplanted groups	27993
@NP	moderate	28021
@NP	neurological outcome	28057
@NP	contrast	28082
@NP	the amplitude of MEPs and SSEPs	28092
@NP	the amplitude	28092
@NP	MEPs and SSEPs	28109
@NP	OEC	28147
@NP	SC-transplanted groups	28156
@NP	the medium-injected group	28187
@NP	The use of electrophysiological techniques	28214
@NP	The use	28214
@NP	electrophysiological techniques	28225
@NP	detection	28264
@NP	functional differences	28277
@NP	spinal cord-injured groups	28308
@NP	gross neurological evaluations of locomotor behavior	28357
@NP	gross neurological evaluations	28357
@NP	locomotor behavior	28391
@NP	Loy et al. , 2002 ; GarcÄ± ' a-AlÄ± ' as et al. , 2003	28411
@NP	Loy	28411
@NP	et al. , 2002 ; GarcÄ± ' a-AlÄ± ' as et al. , 2003	28415
@NP	et al. , 2002	28415
@NP	et al.	28415
@NP	2002	28423
@NP	GarcÄ± ' a-AlÄ± ' as et al. , 2003	28429
@NP	GarcÄ± ' a-AlÄ±	28429
@NP	GarcÄ± '	28429
@NP	et al.	28444
@NP	2003	28452
@NP	Supramaximal transcranial stimulation	28459
@NP	depolarization	28506
@NP	cortical and brainstem motor neurons	28524
@NP	the impulse	28578
@NP	the spinal cord to synapse	28596
@NP	the spinal cord	28596
@NP	synapse	28615
@NP	lumbar motoneurons -LRB- Konrad et al. , 1990 -RRB-	28638
@NP	lumbar motoneurons	28638
@NP	Konrad	28658
@NP	et al. , 1990	28665
@NP	et al.	28665
@NP	1990	28673
@NP	Injuries of the spinal cord compromise	28680
@NP	Injuries	28680
@NP	the spinal cord compromise	28692
@NP	the preservation of MEPs , mainly when the lateral funiculi are lesioned	28719
@NP	the preservation	28719
@NP	MEPs , mainly	28739
@NP	MEPs	28739
@NP	the lateral funiculi	28757
@NP	Adamson et al. , 1989	28792
@NP	Adamson	28792
@NP	et al.	28800
@NP	1989	28808
@NP	The maintenance of MEPs in OECand SC-grafted groups	28815
@NP	The maintenance	28815
@NP	MEPs in OECand SC-grafted groups	28834
@NP	MEPs	28834
@NP	OECand SC-grafted groups	28842
@NP	the greater sparing of the lateral funiculi in these animals	28891
@NP	the greater sparing	28891
@NP	the lateral funiculi in these animals	28914
@NP	the lateral funiculi	28914
@NP	these animals	28938
@NP	DM animals	28966
@NP	the other hand	28981
@NP	the low-intensity stimuli	28997
@NP	the tibial nerve	29034
@NP	the SSEPs	29060
@NP	excitation	29078
@NP	large , myelinated afferent fibers	29092
@NP	the dorsal column spinal pathway -LRB- Fehlings et al. , 1988 -RRB-	29154
@NP	the dorsal column spinal pathway	29154
@NP	Fehlings	29188
@NP	et al. , 1988	29197
@NP	et al.	29197
@NP	1988	29205
@NP	other afferent spinal tracts	29221
@NP	mainly the spinocerebellar tracts	29264
@NP	the dorsal and middle aspect of the lateral funiculi -LRB- York , 1985 -RRB-	29315
@NP	the dorsal and middle aspect	29315
@NP	the lateral funiculi -LRB- York , 1985 -RRB-	29347
@NP	the lateral funiculi	29347
@NP	York	29369
@NP	1985	29375
@NP	The presence of SSEPs in all our injured groups	29382
@NP	The presence	29382
@NP	SSEPs in all our injured groups	29398
@NP	SSEPs	29398
@NP	all our injured groups	29407
@NP	multiple spinal pathways contributing to the recorded signals	29447
@NP	multiple spinal pathways	29447
@NP	the recorded signals	29488
@NP	the different preservation of dorsolateral funiculi	29517
@NP	the different preservation	29517
@NP	dorsolateral funiculi	29547
@NP	the maintenance of SSEPs	29583
@NP	the maintenance	29583
@NP	SSEPs	29602
@NP	injury	29614
@NP	amplitudes	29626
@NP	the OEC and SC groups	29671
@NP	the DM group	29701
@NP	The amplitude values of MEPs and SSEPs	29715
@NP	The amplitude values	29715
@NP	MEPs and SSEPs	29739
@NP	noticeable changes in group DM	29771
@NP	noticeable changes	29771
@NP	group DM	29793
@NP	follow-up	29809
@NP	they	29828
@NP	14 dpo	29857
@NP	later tests in grafted groups	29867
@NP	later tests	29867
@NP	grafted groups	29882
@NP	This	29898
@NP	regeneration of a population of injured axons spanning the lesion site	29919
@NP	regeneration	29919
@NP	a population of injured axons spanning the lesion site	29935
@NP	a population	29935
@NP	injured axons spanning the lesion site	29951
@NP	injured axons	29951
@NP	the lesion site	29974
@NP	remyelination of demyelinated axons by the grafted glial cells	29996
@NP	remyelination	29996
@NP	axons	30026
@NP	the grafted glial cells	30035
@NP	spinal cord injury	30066
@NP	the facilitation of spinal reflexes	30086
@NP	the facilitation	30086
@NP	spinal reflexes	30106
@NP	the development of hyperreflexia	30131
@NP	the development	30131
@NP	hyperreflexia	30150
@NP	This phenomenon	30165
@NP	an increase of the H/M ratio	30219
@NP	an increase	30219
@NP	the H/M ratio	30234
@NP	The increase of reflex excitability	30249
@NP	The increase	30249
@NP	reflex excitability	30265
@NP	the interruption of descending input	30295
@NP	the interruption	30295
@NP	descending input	30315
@NP	supraspinal nuclei	30337
@NP	presynaptic inhibition of Ia muscle afferents	30379
@NP	presynaptic inhibition	30379
@NP	Ia muscle afferents	30405
@NP	spinal interneurons -LRB- Calancie et al. , 1993 -RRB-	30428
@NP	spinal interneurons	30428
@NP	Calancie	30449
@NP	et al. , 1993	30458
@NP	et al.	30458
@NP	1993	30466
@NP	changes in motoneuron excitability -LRB- Chen et al. , 2000 -RRB-	30479
@NP	changes	30479
@NP	motoneuron excitability -LRB- Chen et al. , 2000 -RRB-	30490
@NP	motoneuron excitability	30490
@NP	Chen	30515
@NP	et al. , 2000	30520
@NP	et al.	30520
@NP	2000	30528
@NP	The three experimental groups	30535
@NP	a high H/M ratio	30575
@NP	an increase in the H reflex wave amplitude	30603
@NP	an increase	30603
@NP	the H reflex wave amplitude	30618
@NP	early stages of follow-up	30649
@NP	early stages	30649
@NP	follow-up	30665
@NP	The ratio	30676
@NP	normal values	30706
@NP	time	30725
@NP	the two	30733
@NP	groups	30749
@NP	the OEC group	30765
@NP	the SC group	30787
@NP	it	30809
@NP	elevated in the control group	30821
@NP	elevated	30821
@NP	the control group	30833
@NP	The normalization of the H reflex response in the grafted groups	30852
@NP	The normalization	30852
@NP	the H reflex response in the grafted groups	30873
@NP	the H reflex response	30873
@NP	the grafted groups	30898
@NP	preservation of the spinal descending pathways	30936
@NP	preservation	30936
@NP	the spinal descending pathways	30952
@NP	supraspinal control	31019
@NP	The tracing evaluation of the corticospinal tract	31040
@NP	The tracing evaluation	31040
@NP	the corticospinal tract	31066
@NP	spared/regenerated axons	31097
@NP	three OEC-transplanted animals	31130
@NP	the other hand	31165
@NP	immunostaining of 5-HT-positive fibers at T13	31181
@NP	immunostaining	31181
@NP	5-HT-positive fibers at T13	31199
@NP	5-HT-positive fibers	31199
@NP	T13	31223
@NP	no appreciable differences between groups	31234
@NP	no appreciable differences	31234
@NP	groups	31269
@NP	Brainstem serotoninergic neurons	31277
@NP	a high capability for collateral sprouting	31315
@NP	a high capability	31315
@NP	collateral sprouting	31337
@NP	collateral	31337
@NP	this	31363
@NP	the cause for the lack of differences between our injured groups	31377
@NP	the cause	31377
@NP	the lack of differences between our injured groups	31391
@NP	the lack	31391
@NP	differences between our injured groups	31403
@NP	differences	31403
@NP	our injured groups	31423
@NP	This	31443
@NP	the ability of all the animals	31467
@NP	the ability	31467
@NP	all the animals	31482
@NP	injury -LRB- Jacobs et al. , 2002 -RRB-	31512
@NP	injury	31512
@NP	Jacobs	31520
@NP	et al. , 2002	31527
@NP	et al.	31527
@NP	2002	31535
@NP	Our histological results	31542
@NP	the three experimental groups	31579
@NP	p75-positive cells at the injury site	31613
@NP	p75-positive cells	31613
@NP	the injury site	31635
@NP	Both SCs and OECs	31652
@NP	p75 antibody labeling	31685
@NP	Spontaneous and local infiltration of SCs from the dorsal roots	31708
@NP	Spontaneous and local infiltration	31708
@NP	SCs from the dorsal roots	31746
@NP	SCs	31746
@NP	the dorsal roots	31755
@NP	photochemical	31785
@NP	contusion	31800
@NP	compression injuries	31815
@NP	the spinal cord	31839
@NP	Felts and Smith , 1992 ; Bunge et al. , 1994 ; Beattie et al. , 1997	31856
@NP	Felts and Smith	31856
@NP	Felts	31856
@NP	Smith	31866
@NP	1992 ; Bunge et al.	31873
@NP	1992	31873
@NP	Bunge et al.	31879
@NP	Bunge	31879
@NP	et al.	31885
@NP	1994 ; Beattie et al. , 1997	31893
@NP	1994	31893
@NP	Beattie et al. , 1997	31899
@NP	Beattie	31899
@NP	et al. , 1997	31907
@NP	et al.	31907
@NP	1997	31915
@NP	both glia-transplanted groups	31931
@NP	more p75-positive cells	31965
@NP	the DM group	31994
@NP	This finding	32008
@NP	survival of transplanted cells at the injury site	32038
@NP	survival	32038
@NP	transplanted cells at the injury site	32050
@NP	transplanted cells	32050
@NP	the injury site	32072
@NP	further studies with specific labels for OECs and for SCs	32098
@NP	further studies	32098
@NP	specific labels for OECs	32119
@NP	specific labels	32119
@NP	OECs	32139
@NP	SCs	32152
@NP	the differential survival and migration	32189
@NP	each type of glial cell transplanted in vivo -LRB- Takami et al. , 2002 -RRB-	32232
@NP	each type	32232
@NP	glial cell transplanted in vivo	32245
@NP	glial cell	32245
@NP	Takami	32278
@NP	et al. , 2002	32285
@NP	et al.	32285
@NP	2002	32293
@NP	The OEC-grafted animals	32300
@NP	lower GFAP and proteoglycan immunoreactivity in astrocytes	32331
@NP	lower GFAP and proteoglycan immunoreactivity	32331
@NP	astrocytes	32379
@NP	SC and DM groups	32395
@NP	previous studies	32416
@NP	we	32434
@NP	OEC transplantation into spinal cords subjected to photochemical injury	32449
@NP	OEC transplantation	32449
@NP	spinal cords subjected to photochemical injury	32474
@NP	spinal cords	32474
@NP	photochemical injury	32500
@NP	astrocytic reactivity	32529
@NP	the hypertrophy and the expression of GFAP and proteoglycans	32564
@NP	the hypertrophy	32564
@NP	the expression of GFAP and proteoglycans	32584
@NP	the expression	32584
@NP	GFAP and proteoglycans	32602
@NP	the control injured spinal cord -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	32640
@NP	the control	32640
@NP	spinal cord -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	32660
@NP	spinal cord	32660
@NP	Verdu ' et al.	32673
@NP	Verdu ' et	32673
@NP	Verdu '	32673
@NP	et	32680
@NP	al.	32683
@NP	2001 , 2003b	32688
@NP	2001	32688
@NP	2003b	32694
@NP	In vitro studies	32702
@NP	proteoglycan	32737
@NP	neurite outgrowth -LRB- Bovolenta et al. , 1997 -RRB-	32759
@NP	neurite outgrowth	32759
@NP	Bovolenta	32778
@NP	et al. , 1997	32788
@NP	et al.	32788
@NP	1997	32796
@NP	Plant et al. -LRB- 2001 -RRB-	32813
@NP	Plant et al.	32813
@NP	Plant	32813
@NP	et al.	32819
@NP	2001	32827
@NP	CSPG immunoreactivity	32847
@NP	the distal SC graft -- host cord interface	32886
@NP	the distal SC graft	32886
@NP	host cord interface	32907
@NP	it	32932
@NP	astrocytes and fibroblasts	32964
@NP	transplanted SCs	33005
@NP	These findings	33023
@NP	accumulation of proteoglycan compounds near the wound	33051
@NP	accumulation	33051
@NP	proteoglycan compounds near the wound	33067
@NP	proteoglycan compounds	33067
@NP	the wound	33095
@NP	the elongation of injured central axons	33116
@NP	the elongation	33116
@NP	injured central axons	33134
@NP	The modulation of astrocyte	33157
@NP	The modulation	33157
@NP	astrocyte	33175
@NP	the presence of OEC	33199
@NP	the presence	33199
@NP	OEC	33215
@NP	SCs raises the question of possible communication	33230
@NP	SCs	33230
@NP	the question of possible communication	33241
@NP	the question	33241
@NP	possible communication	33257
@NP	cell contact	33291
@NP	secretion of soluble factors	33310
@NP	secretion	33310
@NP	soluble factors	33323
@NP	cell types	33348
@NP	These phenomena	33360
@NP	the transient hypertrophy and up-regulation of GFAP in olfactory bulb astrocytes	33390
@NP	the transient hypertrophy and up-regulation	33390
@NP	GFAP in olfactory bulb astrocytes	33437
@NP	GFAP	33437
@NP	olfactory bulb astrocytes	33445
@NP	a transection of the olfactory nerve	33477
@NP	a transection	33477
@NP	the olfactory nerve	33494
@NP	transplantation	33523
@NP	mature glial scars of preinjured optic nerve into transected olfactory nerve	33542
@NP	mature glial scars	33542
@NP	preinjured optic nerve into transected olfactory nerve	33564
@NP	preinjured optic nerve	33564
@NP	transected olfactory nerve	33592
@NP	astrocyte reactiveness	33629
@NP	axonal regeneration -LRB- Anders and Hurlock , 1996	33664
@NP	axonal regeneration -LRB- Anders and Hurlock	33664
@NP	axonal regeneration	33664
@NP	Anders and Hurlock	33685
@NP	Anders	33685
@NP	Hurlock	33696
@NP	1996	33705
@NP	Previous studies	33712
@NP	both OEC and SC grafts	33743
@NP	OEC	33748
@NP	SC grafts	33756
@NP	functional recovery	33778
@NP	spinal cord injuries	33804
@NP	the adult rat -LRB- Guest et al. , 1997	33828
@NP	the adult rat -LRB- Guest et al. ,	33828
@NP	the adult rat	33828
@NP	Guest et al.	33843
@NP	Guest	33843
@NP	et al.	33849
@NP	1997	33857
@NP	Xu et al. , 1997	33863
@NP	Xu	33863
@NP	et al. , 1997	33866
@NP	et al.	33866
@NP	1997	33874
@NP	Ramo ' n-Cueto et al. , 2000	33880
@NP	Ramo ' n-Cueto et al.	33880
@NP	Ramo ' n-Cueto	33880
@NP	Ramo '	33880
@NP	et al.	33893
@NP	2000	33901
@NP	Pinzo 'n et al.	33907
@NP	et al.	33915
@NP	2001	33923
@NP	Plant et information	33929
@NP	the effects of OEC or SC grafts	33967
@NP	the effects	33967
@NP	OEC or SC grafts	33982
@NP	the same spinal cord injury model	34002
@NP	Imaizumi et al. -LRB- 1998 , 2000 -RRB-	34037
@NP	Imaizumi et al.	34037
@NP	Imaizumi	34037
@NP	et al.	34046
@NP	1998	34054
@NP	2000	34060
@NP	either OECs or SCs	34077
@NP	OECs	34084
@NP	SCs	34092
@NP	long-distance regeneration of functionally remyelinated axons	34118
@NP	long-distance regeneration	34118
@NP	functionally remyelinated axons	34148
@NP	the spinal cord	34187
@NP	dorsal column transection	34209
@NP	the other hand	34239
@NP	Takami	34255
@NP	et al. -LRB- 2002 -RRB-	34262
@NP	et al.	34262
@NP	2002	34270
@NP	SC grafts	34299
@NP	axonal sparing/regeneration	34342
@NP	OEC grafts	34375
@NP	only SC grafts	34395
@NP	the hindlimb locomotor performance	34419
@NP	animals subjected to moderate contusion of the thoracic spinal cord	34457
@NP	animals	34457
@NP	moderate contusion of the thoracic spinal cord	34478
@NP	moderate contusion	34478
@NP	the thoracic spinal cord	34500
@NP	Our results	34526
@NP	those of Takami et al. , -LRB- 2002 -RRB- in that	34550
@NP	those	34550
@NP	Takami et al. , -LRB- 2002 -RRB- in that	34559
@NP	Takami et al. , -LRB- 2002 -RRB-	34559
@NP	Takami	34559
@NP	et al.	34566
@NP	2002	34575
@NP	that	34584
@NP	OEC and SC transplants	34594
@NP	tissue preservation and functional recovery	34626
@NP	tissue preservation	34626
@NP	a mild photochemical injury	34676
@NP	OEC grafts	34709
@NP	the best results	34725
@NP	Several reasons	34743
@NP	the differences	34771
@NP	these studies	34801
@NP	the effects of glial cell grafts	34823
@NP	the effects	34823
@NP	glial cell grafts	34838
@NP	the type and severity of the spinal cord injury	34880
@NP	the type and severity	34880
@NP	the spinal cord injury	34905
@NP	the contusion injury induced in the work of Takami et al. -LRB- 2002 -RRB-	34944
@NP	the contusion injury	34944
@NP	the work of Takami et al. -LRB- 2002 -RRB-	34976
@NP	the work	34976
@NP	Takami et al. -LRB- 2002 -RRB-	34988
@NP	Takami et al.	34988
@NP	Takami	34988
@NP	et al.	34995
@NP	2002	35003
@NP	the lesion induced by our photochemical method	35030
@NP	the lesion	35030
@NP	our photochemical method	35052
@NP	the time interval between injury and cell grafting	35086
@NP	the time interval	35086
@NP	injury and cell grafting	35112
@NP	Takami et al. -LRB- 2002 -RRB-	35157
@NP	Takami et al.	35157
@NP	Takami	35157
@NP	et al.	35164
@NP	2002	35172
@NP	the cells	35186
@NP	7 days	35196
@NP	the injury	35209
@NP	we	35229
@NP	only 30 min	35245
@NP	injury	35263
@NP	this regard	35274
@NP	Martin et al. -LRB- 1996 -RRB-	35287
@NP	Martin et al.	35287
@NP	Martin	35287
@NP	et al.	35294
@NP	1996	35302
@NP	immediate -LRB- 30 min -RRB-	35326
@NP	immediate	35326
@NP	30 min	35337
@NP	10-day-delayed SC grafts , but not intermediate -LRB- 4 days -RRB- grafts ,	35348
@NP	10-day-delayed SC grafts	35348
@NP	not intermediate -LRB- 4 days -RRB- grafts	35378
@NP	4 days	35396
@NP	the size of cystic cavitation	35420
@NP	the size	35420
@NP	cystic cavitation	35432
@NP	mildly injured spinal cords	35453
@NP	They	35482
@NP	release of cytotoxic metabolites	35502
@NP	release	35502
@NP	cytotoxic metabolites	35513
@NP	acute transplantation	35557
@NP	10 days	35589
@NP	injury	35603
@NP	these metabolites	35610
@NP	an intermediate stage	35664
@NP	they	35692
@NP	the grafted cells -LRB- Martin et al. , 1996 -RRB-	35717
@NP	the grafted cells	35717
@NP	Martin	35736
@NP	et al. , 1996	35743
@NP	et al.	35743
@NP	1996	35751
@NP	the other hand	35761
@NP	immediate transplantation of OECs	35777
@NP	immediate transplantation	35777
@NP	OECs	35806
@NP	locomotor behavior	35827
@NP	moderate contusion -LRB- Plant et al. , 2003 ; Resnick et al. , 2003 -RRB-	35852
@NP	moderate contusion	35852
@NP	Plant	35872
@NP	et al. , 2003 ; Resnick et al. , 2003	35878
@NP	et al.	35878
@NP	2003 ; Resnick et al.	35886
@NP	2003	35886
@NP	Resnick et al.	35892
@NP	Resnick	35892
@NP	et al.	35900
@NP	2003	35908
@NP	7-day-delayed transplantation	35923
@NP	a slight improvement	35962
@NP	the fact	35992
@NP	tissue preservation	36006
@NP	timings	36048
@NP	Plant et al. , 2003	36057
@NP	Plant	36057
@NP	et al.	36063
@NP	2003	36071
@NP	Third	36078
@NP	the purity and phenotype	36085
@NP	the	36113
@NP	cells	36126
@NP	the transplant -LRB- Imaizumi et al. , 2000 ; Rubio et al. , 2002 -RRB-	36136
@NP	the transplant	36136
@NP	Imaizumi	36152
@NP	et al. , 2000 ; Rubio et al. , 2002	36161
@NP	et al.	36161
@NP	2000 ; Rubio et al.	36169
@NP	2000	36169
@NP	Rubio et al.	36175
@NP	Rubio	36175
@NP	et al.	36181
@NP	2002	36189
@NP	the amount of cells	36196
@NP	the amount	36196
@NP	cells	36210
@NP	the precise site of transplantation	36221
@NP	the precise site	36221
@NP	transplantation	36241
@NP	the results	36277
@NP	Both SCs and OECs	36290
@NP	a number of different molecular markers	36329
@NP	a number	36329
@NP	different molecular markers	36341
@NP	common	36372
@NP	a similar morphological phenotype	36391
@NP	culture	36428
@NP	the same growth-promoting molecules	36451
@NP	Ramo ' n-Cueto and Valverde , 1995 ; Wewetzer et al. , 2002	36488
@NP	Ramo ' n-Cueto and Valverde , 1995 ; Wewetzer et al. ,	36488
@NP	Ramo ' n-Cueto	36488
@NP	Ramo '	36488
@NP	Valverde , 1995 ; Wewetzer et al. ,	36505
@NP	Valverde	36505
@NP	1995 ; Wewetzer et al.	36515
@NP	1995	36515
@NP	Wewetzer et al.	36521
@NP	Wewetzer	36521
@NP	et al.	36530
@NP	2002	36538
@NP	several growth factors	36575
@NP	the survival and regeneration	36611
@NP	different types	36644
@NP	neurons	36663
@NP	Woodhall et al. , 2001 ; Boruch et al. , 2001 ; Lipson et al. , 2003	36672
@NP	Woodhall	36672
@NP	et al. , 2001 ; Boruch et al. , 2001 ; Lipson et al. , 2003	36681
@NP	et al. , 2001	36681
@NP	et al.	36681
@NP	2001	36689
@NP	Boruch et al. , 2001	36695
@NP	Boruch	36695
@NP	et al. , 2001	36702
@NP	et al.	36702
@NP	2001	36710
@NP	Lipson et al. , 2003	36716
@NP	Lipson	36716
@NP	et al. , 2003	36723
@NP	et al.	36723
@NP	2003	36731
@NP	addition	36741
@NP	SCs and OECs	36764
@NP	remyelinate injured spinal axons	36777
@NP	a peripheral type of myelin	36815
@NP	a peripheral type	36815
@NP	myelin	36836
@NP	the conduction properties	36864
@NP	they	36900
@NP	morphological differences -LRB- Imaizumi et al. , 2000 -RRB-	36913
@NP	morphological differences	36913
@NP	Imaizumi	36940
@NP	et al. , 2000	36949
@NP	et al.	36949
@NP	2000	36957
@NP	the differential effects	36979
@NP	OECs but not SCs	37005
@NP	the host spinal cord parenchyma	37045
@NP	Iwashita	37078
@NP	et al. , 2000 ; Boruch et al. , 2001	37087
@NP	et al.	37087
@NP	2000 ; Boruch et al.	37095
@NP	2000	37095
@NP	Boruch et al.	37101
@NP	Boruch	37101
@NP	et al.	37108
@NP	2001	37116
@NP	OECs	37127
@NP	SCs in their interaction	37144
@NP	SCs	37144
@NP	their interaction	37151
@NP	astrocytes -LRB- Lakatos et al. , 2000 ; Verdu ' et al. , 2001 -RRB-	37174
@NP	astrocytes	37174
@NP	Lakatos	37186
@NP	et al. , 2000 ; Verdu ' et al. , 2001	37194
@NP	et al.	37194
@NP	2000 ; Verdu ' et al.	37202
@NP	2000	37202
@NP	Verdu ' et al.	37208
@NP	Verdu '	37208
@NP	et al.	37215
@NP	2001	37223
@NP	a favorable microenvironment	37256
@NP	central regeneration	37289
@NP	ACKNOWLEDGMENTS The authors	37312
@NP	ACKNOWLEDGMENTS	37312
@NP	The authors	37328
@NP	Albert Brillas and Mo ' nica Espejo for technical assistance	37346
@NP	Albert Brillas and Mo ' nica Espejo	37346
@NP	Albert Brillas and Mo '	37346
@NP	technical assistance	37384
@VP	containing 180,000 OECs or SCs	888
@VP	was injected	919
@VP	injected	923
@VP	received the vehicle alone	960
@VP	to evaluate the integrity of spinal cord pathways	1195
@VP	evaluate the integrity of spinal cord pathways	1198
@VP	were evaluated by the H reflex responses	1277
@VP	evaluated by the H reflex responses	1282
@VP	were quantified immunohistochemically at the injured spinal segments	1380
@VP	quantified immunohistochemically at the injured spinal segments	1385
@VP	caudal to the lesion was evaluated	1511
@VP	was evaluated	1532
@VP	evaluated	1536
@VP	had higher MEP amplitudes and lower H responses than the other two groups	1694
@VP	was greater in transplanted than in control injured rats	1819
@VP	Taken together	2012
@VP	has potential for restoration of injured spinal cords	2091
@VP	to reduce glial reactivity and to improve functional recovery	2181
@VP	to reduce glial reactivity	2181
@VP	reduce glial reactivity	2184
@VP	to improve functional recovery	2212
@VP	improve functional recovery	2215
@VP	caused in patients	2375
@VP	encouraged many groups to investigate possible therapies to achieve CNS repair	2399
@VP	to investigate possible therapies to achieve CNS repair	2422
@VP	investigate possible therapies to achieve CNS repair	2425
@VP	to achieve CNS repair	2456
@VP	achieve CNS repair	2459
@VP	ascending	2583
@VP	descending white matter tracts at the site of the injury	2597
@VP	leading to the loss of motor , sensory , and autonomic control	2655
@VP	assayed -LRB- Olson , 1997 ; Horner and Gage , 2000 -RRB-	2777
@VP	enhancing restitution of the lost functions	2886
@VP	have received special attention for bridging the gap after spinal cord injuries	3554
@VP	received special attention for bridging the gap after spinal cord injuries	3559
@VP	bridging the gap after spinal cord injuries	3590
@VP	produced by the SCs	3865
@VP	promotes the elongation of propiospinal and supraspinal axons within the graft	3885
@VP	are believed to be supported by the OECs -LRB- Doucette , 1984 -RRB-	4329
@VP	believed to be supported by the OECs -LRB- Doucette , 1984 -RRB-	4333
@VP	to be supported by the OECs -LRB- Doucette , 1984 -RRB-	4342
@VP	be supported by the OECs -LRB- Doucette , 1984 -RRB-	4345
@VP	supported by the OECs -LRB- Doucette , 1984 -RRB-	4348
@VP	designing future therapeutic strategies for spinal cord injury	4634
@VP	are comparable cell types	4752
@VP	have compared the effects of SC and OEC transplants in injured spinal cords	4950
@VP	compared the effects of SC and OEC transplants in injured spinal cords	4955
@VP	were able to remyelinate the injured spinal cords	5187
@VP	to remyelinate the injured spinal cords	5197
@VP	remyelinate the injured spinal cords	5200
@VP	restore spinal cord conduction	5350
@VP	promote axonal regeneration across the transection site	5385
@VP	grafts acutely transplanted after a photochemical injury to the spinal cord	5711
@VP	studying glial reactivity and spinal cord connectivity	5853
@VP	prepared	6021
@VP	immunopurified	6031
@VP	described in detail elsewhere -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	6068
@VP	thawed at 37 Â°C	6172
@VP	modified Eagle 's medium nutrient	6253
@VP	was resuspended in the same medium	6355
@VP	resuspended in the same medium	6359
@VP	were transplanted within 2 hr of thawing	6401
@VP	transplanted within 2 hr of thawing	6406
@VP	described as having an SClike phenotype	6528
@VP	having an SClike phenotype	6541
@VP	was above 80 %	6699
@VP	anesthetized with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	6817
@VP	placed prone on a heating pad to keep the body temperature constant	6877
@VP	to keep the body temperature constant	6907
@VP	keep the body temperature constant	6910
@VP	was shaved and disinfected with povidone iodine	6969
@VP	shaved and disinfected with povidone iodine	6973
@VP	extending from middle to low thoracic vertebrae	7070
@VP	was made	7118
@VP	made	7122
@VP	was exposed by a dorsal laminectomy at the T8 vertebra	7144
@VP	exposed by a dorsal laminectomy at the T8 vertebra	7148
@VP	dye removed with saline solution rinses	7333
@VP	removed with saline solution rinses	7337
@VP	rinses	7366
@VP	positioned 10 mm above the spinal cord	7433
@VP	connected to a cold light source equipped with a halogen bulb	7473
@VP	equipped with a halogen bulb	7506
@VP	were illuminated with an intensity of 80 kLux for 2.5 min	7557
@VP	illuminated with an intensity of 80 kLux for 2.5 min	7562
@VP	To prevent damage caused by the calorific source of the lamp	7616
@VP	prevent damage caused by the calorific source of the lamp	7619
@VP	caused by the calorific source of the lamp	7634
@VP	received a total of 180,000 OECs or SCs	8025
@VP	received four injections of an equal volume of DMEM alone	8110
@VP	To prevent leakage	8489
@VP	prevent leakage	8492
@VP	was removed from the spinal parenchyma 2 min after the end of each injection	8526
@VP	removed from the spinal parenchyma 2 min after the end of each injection	8530
@VP	sutured with 5-0 silk thread in the muscular plane and small clips in the skin	8627
@VP	disinfected	8710
@VP	were kept in a warm environment until full recovery	8728
@VP	kept in a warm environment until full recovery	8733
@VP	were housed two per cage	8789
@VP	housed two per cage	8794
@VP	were exposed to a 12 hr light/dark cycle	8815
@VP	exposed to a 12 hr light/dark cycle	8820
@VP	had free access to food and water	8861
@VP	were approved by the Ethics Committee of our institution	8924
@VP	approved by the Ethics Committee of our institution	8929
@VP	was evaluated with the open field test	9147
@VP	evaluated with the open field test	9151
@VP	scored on the BBB scale -LRB- Basso et al. , 1995 -RRB-	9190
@VP	placed individually in a circular enclosure and allowed to move freely for 5 min	9253
@VP	placed individually in a circular enclosure	9253
@VP	allowed to move freely for 5 min	9301
@VP	to move freely for 5 min	9309
@VP	move freely for 5 min	9312
@VP	observed the hindlimb movements of the rat	9361
@VP	ranging from 0 -LRB- no movement -RRB- to 21 -LRB- normal movement -RRB-	9465
@VP	to maintain postural stability	9540
@VP	maintain postural stability	9543
@VP	was evaluated with the inclined plane test	9571
@VP	evaluated with the inclined plane test	9575
@VP	were placed on the inclined plane	9624
@VP	placed on the inclined plane	9629
@VP	could maintain its position for 5 sec	9704
@VP	maintain its position for 5 sec	9710
@VP	using a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	9885
@VP	were placed individually inside a plexiglass box on an elevated glass floor	9949
@VP	placed individually inside a plexiglass box on an elevated glass floor	9954
@VP	focusing a light beam directly onto the plantar surface of the hindpaw	10065
@VP	coupled with infrared detectors directed to the plantar surface	10211
@VP	directed to the plantar surface	10243
@VP	was limited to 40 sec to avoid skin damage	10308
@VP	limited to 40 sec to avoid skin damage	10312
@VP	to avoid skin damage	10330
@VP	avoid skin damage	10333
@VP	was the mean of three trials separated by 5-min resting periods	10373
@VP	separated by 5-min resting periods	10402
@VP	circulating pump to maintain skin temperature above 32 Â°C	10708
@VP	to maintain skin temperature above 32 Â°C	10725
@VP	maintain skin temperature above 32 Â°C	10728
@VP	To ensure reproducibility in all the electrophysiological tests	10766
@VP	ensure reproducibility in all the electrophysiological tests	10769
@VP	to ensure the same placement in all animals , guided by anatomical landmarks	10913
@VP	ensure the same placement in all animals , guided by anatomical landmarks	10916
@VP	guided by anatomical landmarks	10958
@VP	to evaluate the integrity of spinal cord ascending and descending pathways	11032
@VP	evaluate the integrity of spinal cord ascending and descending pathways	11035
@VP	ascending and descending pathways	11073
@VP	were elicited by transcranial stimulation with two needle electrodes	11139
@VP	elicited by transcranial stimulation with two needle electrodes	11144
@VP	delivering single electrical pulses of 25 mA intensity and 100 Âµsec duration	11246
@VP	recorded from the tibialis	11328
@VP	amplified	11419
@VP	filtered -LRB- bandpass 1 -- 5,000 Hz -RRB-	11430
@VP	to measure the latency to onset	11519
@VP	measure the latency to onset	11522
@VP	To ensure reproducibility	11616
@VP	ensure reproducibility	11619
@VP	were recorded , with a time interval of 30 sec between stimuli	11670
@VP	recorded , with a time interval of 30 sec between stimuli	11675
@VP	was used for analysis	11778
@VP	used for analysis	11782
@VP	were amplified , filtered -LRB- bandpass 20 -- 1,000 Hz -RRB- , and averaged	12161
@VP	amplified , filtered -LRB- bandpass 20 -- 1,000 Hz -RRB- , and averaged	12166
@VP	amplified	12166
@VP	filtered -LRB- bandpass 20 -- 1,000 Hz -RRB-	12177
@VP	averaged	12214
@VP	were measured -LRB- Nuwe , 1998 ; GarcÄ± ' a-AlÄ± ' as et al. , 2003 -RRB-	12300
@VP	measured -LRB- Nuwe , 1998 ; GarcÄ± ' a-AlÄ± ' as et al. , 2003 -RRB-	12305
@VP	were performed to evaluate the lumbar H reflex	12388
@VP	performed to evaluate the lumbar H reflex	12393
@VP	to evaluate the lumbar H reflex	12403
@VP	evaluate the lumbar H reflex	12406
@VP	delivered by monopolar needles inserted percutaneously at the sciatic notch	12546
@VP	inserted percutaneously at the sciatic notch	12577
@VP	were recorded by means of needle electrodes and displayed on the oscilloscope	12701
@VP	were recorded by means of needle electrodes	12701
@VP	recorded by means of needle electrodes	12706
@VP	displayed on the oscilloscope	12749
@VP	were measured -LRB- Valero-Cabre ' and Navarro , 2002 -RRB-	12881
@VP	measured -LRB- Valero-Cabre ' and Navarro , 2002 -RRB-	12886
@VP	was calculated	12966
@VP	calculated	12970
@VP	centered at a point 2 mm lateral to Bregma	13351
@VP	was made	13394
@VP	made	13398
@VP	was cut	13413
@VP	cut	13417
@VP	was made into the sensorimotor cortex	13447
@VP	made into the sensorimotor cortex	13451
@VP	became approximated and covered the crystals -LRB- Tsai et al. , 2001 -RRB-	13689
@VP	approximated and covered the crystals -LRB- Tsai et al. , 2001 -RRB-	13696
@VP	approximated	13696
@VP	covered the crystals -LRB- Tsai et al. , 2001 -RRB-	13713
@VP	was sutured and disinfected	13773
@VP	sutured and disinfected	13777
@VP	identified , removed , postfixed overnight in the same solution	14012
@VP	identified	14012
@VP	removed	14024
@VP	stored in a cryoprotection solution -LRB- 30 % sucrose in 0.1 MPBS -RRB- at 4 Â°C	14079
@VP	were cut serially into 40-Âµm-thick transverse sections	14190
@VP	cut serially into 40-Âµm-thick transverse sections	14195
@VP	stored free-floating in De Olmos antifreeze buffer	14249
@VP	were anesthetized and perfused transcardially	14326
@VP	removed and processed as described above -LRB- group CNT -RRB-	14406
@VP	described above -LRB- group CNT -RRB-	14431
@VP	washed in PBS , mounted on gelatin-coated slides ,	14486
@VP	mounted on gelatin-coated slides	14501
@VP	mounted on gelatin-coated slides	15392
@VP	dehydrated in ethanol	15426
@VP	mounted with dextropropoxyphene -LRB- DPX ; Fluka -RRB-	15453
@VP	evaluating antibody specificity	15503
@VP	were processed as described above	15550
@VP	processed as described above	15555
@VP	described above	15568
@VP	were not added	15606
@VP	added	15615
@VP	equipped with epifluorescence using appropriate filters	15680
@VP	using appropriate filters	15710
@VP	To visualize the serotoninergic descending pathways from brainstem raphe nuclei	15737
@VP	visualize the serotoninergic descending pathways from brainstem raphe nuclei	15740
@VP	were taken with the aid of a digital camera	15989
@VP	taken with the aid of a digital camera	15994
@VP	attached to the microscope and analyzed using NIH Image software	16048
@VP	attached to the microscope	16048
@VP	analyzed using NIH Image software	16079
@VP	using NIH Image software	16088
@VP	quantify the preserved spinal cord parenchyma at the lesion site -LRB- T8 -RRB-	16155
@VP	seen in reactive astrocytes surrounding and delimiting the destroyed parenchyma	16260
@VP	surrounding and delimiting the destroyed parenchyma	16288
@VP	surrounding	16288
@VP	delimiting the destroyed parenchyma	16304
@VP	analyzed	16497
@VP	was the mean value of both subjects -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	16506
@VP	were used for measuring the GFAP staining	16646
@VP	used for measuring the GFAP staining	16651
@VP	measuring the GFAP staining	16660
@VP	were collected -LRB- a total of six images per rat -RRB-	16857
@VP	collected -LRB- a total of six images per rat -RRB-	16862
@VP	using a x40 lens	16904
@VP	was quantified by the method described by AcarÄ± 'n et al. -LRB- 1997 -RRB-	16955
@VP	quantified by the method described by AcarÄ± 'n et al. -LRB- 1997 -RRB-	16959
@VP	described by AcarÄ± 'n et al. -LRB- 1997 -RRB-	16984
@VP	referred to as the `` reactive grade	17037
@VP	to	17046
@VP	immunolabeled against CSPG	17215
@VP	described by Plant et al. -LRB- 2001 -RRB-	17329
@VP	were analyzed using NIH Image software	17387
@VP	analyzed using NIH Image software	17392
@VP	using NIH Image software	17401
@VP	were collected and measured	17563
@VP	collected and measured	17568
@VP	were performed in a blinded manner	17683
@VP	performed in a blinded manner	17688
@VP	was used	17759
@VP	used	17763
@VP	are shown as the mean	17774
@VP	shown as the mean	17778
@VP	are expressed as the percentage with respect to preoperative values for each rat	17837
@VP	expressed as the percentage with respect to preoperative values for each rat	17841
@VP	were made with Kruskal-Wallis and Mann-Whitney U-tests	17958
@VP	made with Kruskal-Wallis and Mann-Whitney U-tests	17963
@VP	were considered significant at P < .05	18026
@VP	considered significant at P < .05	18031
@VP	< .05	18059
@VP	Fig. 1	18075
@VP	immunostained against GFAP -LRB- A -- C -RRB- and CSPG -LRB- D -- F -RRB-	19281
@VP	promote sparing of the injured dorsolateral areas of the spinal cord	19436
@VP	showing the dorsal corticospinal tract	19543
@VP	were noted	19843
@VP	noted	19848
@VP	increased over time	19886
@VP	presented moderate locomotor deficits	20104
@VP	coordinated	20180
@VP	scoring 16 Â± 1 and 18 Â± 0.5 , respectively	20264
@VP	stepping	20363
@VP	and SC-grafted animals showed fluidity and velocity in their movements	20634
@VP	maintained only	20709
@VP	recovered stability and balanced locomotion	20779
@VP	were found at the end of follow-up -LRB- Fig. 1A -RRB-	20851
@VP	found at the end of follow-up -LRB- Fig. 1A -RRB-	20856
@VP	are shown in Figure 1B	20979
@VP	shown in Figure 1B	20983
@VP	decreased with respect to preoperative values	21043
@VP	were found between group DM and the two transplanted groups	21197
@VP	found between group DM and the two transplanted groups	21202
@VP	to maintain stances at higher angles	21314
@VP	maintain stances at higher angles	21317
@VP	obtained with the plantar algesimeter test	21431
@VP	ranged between 14 and 16 sec in preoperative controls	21474
@VP	occurred at higher temperatures and consequently at longer latencies	21559
@VP	were 19 Â± 1 , 18 Â± 1 , and 23 Â± 2 in OEC , SC , and DM groups , respectively	21669
@VP	were observed after spinal cord injury in any experimental group	22118
@VP	observed after spinal cord injury in any experimental group	22123
@VP	increased in group OEC	22361
@VP	decreased slightly in group SC , and decreased markedly in group DM	22385
@VP	decreased slightly in group SC	22385
@VP	decreased markedly in group DM	22421
@VP	being significantly lower in group DM than in the other two groups	22579
@VP	consisted of a sequence of negative and positive peaks -LRB- Fig. 2E -RRB-	22684
@VP	were consistently recorded in all the animals	22801
@VP	recorded in all the animals	22819
@VP	being the most affected	23029
@VP	recovered partially in OEC and SC animals	23172
@VP	were found between the DM group and the SC and OEC groups	23239
@VP	found between the DM group and the SC and OEC groups	23244
@VP	recorded in the tibialis anterior muscle -LRB- Fig. 2I -RRB-	23427
@VP	remained almost unchanged during 90 dpo in all the animals -LRB- Fig. 4A -RRB-	23547
@VP	increase -LRB- Fig. 2J -- L -RRB-	23668
@VP	in consequence the H/M ratio increased after injury	23694
@VP	increased after injury	23723
@VP	was lower	23848
@VP	were found because of the large interindividual variability	23974
@VP	found because of the large interindividual variability	23979
@VP	previously described -LRB- Verdu	24341
@VP	was surrounded by scar tissue , strongly immunostained with anti-GFAP	24397
@VP	surrounded by scar tissue , strongly immunostained with anti-GFAP	24401
@VP	strongly immunostained with anti-GFAP	24428
@VP	found in group DM	24879
@VP	heavily stained for GFAP	24924
@VP	were present in the spinal cord parenchyma	24950
@VP	had longer and thicker processes than the OEC animals	25036
@VP	was seen in cord sections of all the experimental groups	25268
@VP	seen in cord sections of all the experimental groups	25272
@VP	was found surrounding the cavity -LRB- Fig. 5D -- F -RRB-	25349
@VP	found surrounding the cavity -LRB- Fig. 5D -- F -RRB-	25353
@VP	surrounding the cavity -LRB- Fig. 5D -- F -RRB-	25359
@VP	were found between group DM and the other two groups -LRB- P < .05 -RRB-	25540
@VP	found between group DM and the other two groups -LRB- P < .05 -RRB-	25545
@VP	forming a dense meshwork within the dorsal area	25697
@VP	were detectable within ventral areas of the injured spinal cord	25768
@VP	adopted a long , bipolar morphology	25907
@VP	were seen in the lateral and ventral gray matter and in the white matter tracts	26129
@VP	seen in the lateral and ventral gray matter and in the white matter tracts	26134
@VP	was similar in the spinal cord sections of all groups -LRB- Fig. 6D -- F -RRB-	26223
@VP	taken at the T1 level from all rats	26361
@VP	was seen in the ventral aspect of the dorsal columns	26418
@VP	seen in the ventral aspect of the dorsal columns	26422
@VP	corresponding	26472
@VP	exerts neuroprotective effects on the spinal cord parenchyma of animals	26778
@VP	subjected to photochemical injury of the thoracic spinal cord	26850
@VP	was achieved in OEC - and SCtransplanted rats than in control DM rats	27006
@VP	achieved in OEC - and SCtransplanted rats than in control DM rats	27010
@VP	see Verdu ' et al. , 2003a	27416
@VP	remained unaffected	27591
@VP	injured rats was mildly involved -LRB- scores 15 -- 16 on the BBB scale -RRB-	27646
@VP	was mildly involved	27659
@VP	resulting in poor scores in the open field test -LRB- Schut et al. , 2002 -RRB-	27842
@VP	induced by cell grafts	27969
@VP	had moderate but significantly improved neurological outcome	28017
@VP	had moderate	28017
@VP	significantly improved neurological outcome	28034
@VP	may be masked in gross neurological evaluations of locomotor behavior	28340
@VP	be masked in gross neurological evaluations of locomotor behavior	28344
@VP	masked in gross neurological evaluations of locomotor behavior	28347
@VP	propagate the impulse along the spinal cord to synapse	28568
@VP	depolarize lumbar motoneurons -LRB- Konrad et al. , 1990 -RRB-	28627
@VP	are lesioned	28778
@VP	lesioned	28782
@VP	is suggestive of multiple spinal pathways contributing to the recorded signals	29430
@VP	contributing to the recorded signals	29472
@VP	were significantly higher in the OEC and SC groups than in the DM group	29642
@VP	increased slightly from 14 dpo to later tests in grafted groups	29833
@VP	spanning the lesion site	29965
@VP	demyelinated axons by the grafted glial cells	30013
@VP	leads to the development of hyperreflexia	30122
@VP	is electrophysiologically detected by an increase of the H/M ratio	30181
@VP	detected by an increase of the H/M ratio	30207
@VP	remained elevated in the control group	30812
@VP	is attributable to preservation of the spinal descending pathways	30917
@VP	partially recovered supraspinal control	30999
@VP	showed spared/regenerated axons only in three OEC-transplanted animals	31090
@VP	showed no appreciable differences between groups	31227
@VP	have a high capability for collateral sprouting	31310
@VP	sprouting	31348
@VP	might be the cause for the lack of differences between our injured groups	31368
@VP	be the cause for the lack of differences between our injured groups	31374
@VP	to walk after injury -LRB- Jacobs et al. , 2002 -RRB-	31498
@VP	walk after injury -LRB- Jacobs et al. , 2002 -RRB-	31501
@VP	had p75-positive cells at the injury site	31609
@VP	are stained by p75 antibody labeling	31670
@VP	stained by p75 antibody labeling	31674
@VP	had more p75-positive cells than the DM group	31961
@VP	transplanted in vivo	32256
@VP	subjected to photochemical injury	32487
@VP	diminishing the hypertrophy and the expression of GFAP and proteoglycans	32552
@VP	injured spinal cord -LRB- Verdu ' et al. , 2001 , 2003b -RRB-	32652
@VP	inhibits neurite outgrowth -LRB- Bovolenta et al. , 1997 -RRB-	32750
@VP	was increased at the distal SC graft -- host cord interface	32869
@VP	increased at the distal SC graft -- host cord interface	32873
@VP	may impair the elongation of injured central axons	33105
@VP	impair the elongation of injured central axons	33109
@VP	raises the question of possible communication	33234
@VP	maintains astrocyte reactiveness	33619
@VP	impedes axonal regeneration -LRB- Anders and Hurlock , 1996	33656
@VP	comparing the effects of OEC or SC grafts in the same spinal cord injury model	33957
@VP	were more effective in promoting axonal sparing/regeneration than OEC grafts	34309
@VP	promoting axonal sparing/regeneration than OEC grafts	34332
@VP	subjected to moderate contusion of the thoracic spinal cord	34465
@VP	differ from those of Takami et al. , -LRB- 2002 -RRB- in that	34538
@VP	gave the best results	34720
@VP	may explain the differences found between these studies	34759
@VP	explain the differences found between these studies	34763
@VP	found between these studies	34787
@VP	may differ depending on the type and severity of the spinal cord injury	34856
@VP	differ depending on the type and severity of the spinal cord injury	34860
@VP	induced in the work of Takami et al. -LRB- 2002 -RRB-	34965
@VP	was more severe than the lesion induced by our photochemical method	35009
@VP	induced by our photochemical method	35041
@VP	was also different	35137
@VP	transplanted only 30 min after injury	35232
@VP	reduced the size of cystic cavitation in mildly injured spinal cords	35412
@VP	could be prevented by acute transplantation	35535
@VP	be prevented by acute transplantation	35541
@VP	prevented by acute transplantation	35544
@VP	could have been cleared	35628
@VP	have been cleared	35634
@VP	been cleared	35639
@VP	cleared	35644
@VP	could be harmful to the grafted cells -LRB- Martin et al. , 1996 -RRB-	35697
@VP	be harmful to the grafted cells -LRB- Martin et al. , 1996 -RRB-	35703
@VP	was similar with both timings -LRB- Plant et al. , 2003 -RRB-	36026
@VP	may strongly affect the results	36257
@VP	affect the results	36270
@VP	to display a similar morphological phenotype in culture	36380
@VP	display a similar morphological phenotype in culture	36383
@VP	display morphological differences -LRB- Imaizumi et al. , 2000 -RRB-	36905
@VP	regard to the differential effects	36969
@VP	being capable of creating a favorable microenvironment for central regeneration	37230
@VP	creating a favorable microenvironment for central regeneration	37247
@VP	thank Albert Brillas and Mo ' nica Espejo for technical assistance	37340
